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ABSTRACT
Chemical production impacts the environment and human health. Many common
products contain chemicals that can be detrimental to human health and more specifically
harmful to the endocrine system. Many individuals and institutions unknowingly buy
products containing chemicals that can harm the endocrine system. I developed a score
that examines the level of harm that these chemicals pose to the endocrine health of the
general population. The implications of Colby’s purchasing practices are discussed.
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INTRODUCTION
Environmental Health Issues
As the global population has increased, the consumption of natural resources has
intensified to meet the population’s rapidly growing demands. Our consumption has led
to the production of ever-increasing products for our daily life and commerce and that has
led to many human-made substances polluting the water, air and land. World War II
prompted massive growth in the synthetic chemical industry, which resulted in thousands
of chemicals whose impacts on human health and the environment were mainly
unknown. The long-term impacts of exploiting these resources for chemical production
on the state of the environment and human health are now becoming increasingly
apparent.
Most manufacturing processes heavily consume natural resources and
contaminate the environment. The use and disposal of many of these products can also
have detrimental impacts on the health of society. Increasing connections are being made
between the chemicals in many of these products and serious ailments such as cancer and
neurological disorders. Many of these products are used daily by millions of people,
exposing them to potentially dangerous levels of these chemicals.

Endocrine Disruption
A wide range of potential health impacts can result from exposure to foreign
chemicals. A current major area of focus is the impacts of these chemicals on the
endocrine system. The endocrine system is a complicated network of glands and
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hormones that regulate the body’s function, illustrated in Figure 1. Growth, maturation,
development and the operation of all the body’s organs rely on the endocrine system. The
pituitary, thyroid, adrenal, thymus, pancreas, ovaries and testes are all glands controlled
by this system.

Figure 1: Overview of the endocrine system and its contributing organs and glands (The Endocrine System,
2006)

Many of these hormones (estrogens, androgens) are steroid hormones and share a similar
structure. Estrogens are the primary female reproductive hormones and there are many
forms, though only a few predominate. Estradiol is the principal estrogen produced in the
ovaries in pre-menopausal woman. Other forms are in the liver, bone, skin, brain, blood
vessel, breast, fat and reproductive tissues. Many of these tissues also have receptors that
respond to estrogen. In the body estrogen stimulates growth in a variety of tissues,
including bone, breast, and endometrial tissues lining the uterus. It also is responsible for
secondary sex characteristics that appear at puberty, increased capillary wall strength and
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blood clotting factor synthesis in the liver. This is very important for women who
routinely lose blood during menstruation and childbirth. Estrogen also promotes HDL
production, which is responsible for removing cholesterol and other fats from the blood,
and donating them to tissues that need fats for growth and new cell production. Estrogen
also exhibits a protective effect on the heart. Androgens, such as testosterone, are
responsible for sperm production, secondary sex characteristics during puberty and
growth, muscle production and hair growth. Sex hormones are also important during
embryonic and fetal development. Both females and males have these two hormones
though at different levels.
Hormones act via a specific receptor in target tissues. Upon binding to a hormone
these receptors move to the nucleus of the cell, where they activate expression of a
certain gene that is involved with hormone action. Figure 2 is a diagram showing how
estradiol works in a cell.

Figure 2: Diagram of estradiol’s role in gene expression in a cell (Rennie, 2005).

9

As you can see here on the diagram, estradiol, the most common estrogen in premenopausal woman, enters the cell and binds with the specific estradiol receptor. Once
bound the activated receptor generally moves into the nucleus of the cell where it
activates a target gene, which is responsible for gene expression. Genes go on to
synthesize proteins in the body, which then dictate the processes such as growth and
maturation. This sequence of events happens millions of times each day with multiple
different hormones in multiple different cells in the body.
Many chemicals can disrupt the delicate balance and interaction of hormones in
the body. The relationship between human disease and endocrine disrupting chemicals is
poorly understood (Lathers, 2002). Chemicals that impact this system are described as
“endocrine disruptors.” Other common names for endocrine disrupting chemicals are
pseudo-androgens and pseudo-estrogens (Lathers, 2002). The EPA defines an endocrine
disruptor as “an exogenous agent that interferes with the synthesis, secretion, transport,
binding, action, or elimination of natural hormones in the body that are responsible for
maintenance of homeostasis, reproduction, development, and/or behavior” (EPA, 1997).
These chemicals can either mimic estrogen or androgens, can be anti-estrogens or antiandrogens, or target the thyroid or other hormones (Lathers, 2007).
These chemicals can have a molecular structure that is similar to those of natural
hormones, such as estradiol or testosterone. They share structural similarities to
hormones, which allow them to have similar receptor binding properties (Lathers, 2002).
Upon binding to the receptors some endocrine disruptors activate hormone receptors
while others block their action. This illustrates a key physiological concept; that structure
determines the function of many chemicals in the body. Figure 3 shows the chemical
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makeup of estrogen, testosterone and two well-known endocrine disrupting chemicals,
DDT and diethylstilbestrol or DES.

Figure 3: Shows the chemical diagrams of two human hormones, estrogen and testosterone and two known
endocrine disrupters, DDT and DES (Dioxins and Furans, 2007).

Sometimes it isn’t apparent from two-dimensional structures how a presumed endocrine
disruptor is structurally related to estrogen and testosterone. A study done by Waller et
al. (1996) suggests that specific electrostatic and steric properties of these chemicals’
three-dimensional structure allow them to interact with the estrogen receptor. In other
words, how they fold up in 3-dimensions and what charges are on their surface
determines binding activities.
The estrogenic activity of endocrine disrupters can be measured in the lab. Table
3 is an example of the estrogenic activity of different endocrine disruptors in comparison
to estradiol, the predominant estrogen in pre-menopausal women. These levels were
determined using estrogen receptor binding or estrogen responsive bioassays. These
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Table 1: Net effect of environmental estrogens (dose x relative potency) (Wolff, 2006).

Morning-after Pill
Birth Control
Hormone Replacement
Dietary Flavanoids

“Estrogen Equivalent” Estradiol
333 x 103
17 x 103
3 x 103
100

numbers do not take into account important factors such as chemical persistence in the
environment.
Naturally occurring compounds act as estrogens in some plants, such as
phytoestrogens in soy. Endocrine disrupting chemicals are also produced synthetically as
industrial chemicals, herbicides, pesticides, fungicides and pharmaceuticals. Table 2 lists
a sampling of substances that are commonly known to have estrogenic activity.

Table 2: A sampling of substances that are known to cause endocrine disruption (Juberg, 1999)
Industrial or Commercial
Chemicals

Pesticide, Fungicide or
Herbicide

Medical or
Pharmaceutical Agent

Food Containing
Phytoestrogens

PCBs
Alkyl phenols and
polyethoxylates
Dibenzofurans

DDT
Methoxychlor
Chlordecone
Vinclozolin
Trifluralin
Parathion

DES
Estrogen replacement
therapy
RU-486
The “pill”
Tamoxifen
Testosterone-enhancing
drugs

Cabbage
Soybean
Sprouts
Legumes

A clear example of an endocrine disrupting chemical is diethylstilbestrol (DES),
which is seen in Table 2 and whose structure is depicted in Figure 3. This potent
synthetic estrogen was administered to thousands of pregnant woman from 1938-1971 as
a medication to prevent miscarriages and subsequently, was found to actually increase the
rate of miscarriages. Woman took the drug because of past or anticipated reproductive
difficulties. Taking the drug resulted in offspring with reproductive problems ranging
from infertility, to birth defects, to rare vaginal cancer in the female children (Colburn,
12

1997). It was later found that mothers who took the drug before their 18th week of
pregnancy had a significantly higher chance of having daughters with the rare vaginal
cancer, clear cell adenocarcinoma. The effects of DES were only discovered when a
group of woman with the same doctor who had administered the drug, developed the rare
vaginal adenocarcinoma.
The DES crisis proved that not only the dose but also the timing of the dose
affects the impacts of a toxin. The interesting facet of the DES problem was that the
severity of the impact on the fetus was not dependent on the dose of the drug but the time
that it was administered. The third generation exposed to DES is just now coming of age
and the reproductive impacts of the drug are becoming apparent. Research in mice has
shown that DES can increase the risk of reproductive cancers in the 3rd generation (CDC,
2007). The number of third generation human cases are limited but some evidence
suggests that the generation is being impacted. A study in 2003 reported ovarian cancer
in a 15 year old, whose grandmother had taken DES (Blatt et al., 2003). Despite that fact
that this is just one case, the rarity of this occurrence suggests that DES could have a
trans-generational impact (Schecter et al., 2005). A Dutch study also reported an
increased incidence of hypospadias in DES exposed third-generation men (Klip et al.,
2002). Researchers hypothesize that in utero exposure to DES may alter oocytes, a cell
from which an egg or sperm develops through meiosis, which then can impact future
generations.
The numbers of suspected endocrine disrupting chemicals is steadily increasing.
The European Union has identified 564 chemicals or groups of chemicals that are
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suspected endocrine disruptors and have isolated 66 of them as “priority” or chemicals
that are suspected to be hazardous (Johnson and Jürgens, 2003).
Increasing evidence suggests that these chemicals are detrimental. Studies have
been done on the reproductive health of workers exposed to pesticides that are suspected
endocrine disruptors. Exposure to various chemicals have caused abortions and stillbirths,
male infertility, neonatal deaths, congenital defects and testicular dysfunction
abnormalities in these workers and their offspring (Kumar et al., 2000). Many cancers are
also linked to hormonal changes such as breast, prostate and thyroid cancer. Many of
these endocrine disruptors are suspected of making the body more susceptible to these
cancers. These chemicals can directly cause cancer or can increase the body’s sensitivity
to a chemical that causes cancer. According to a literature review by the Environmental
Working Group hypospadias, a displacement of the urethral opening, has doubled since
1970, preterm birth has increased since the mid 1980’s and sperm counts have decreased
by 1% yearly since 1934 (EWG, 2005). Some experts believe that the increased exposure
to endocrine disrupting chemicals may have a role in these phenomena.
The data on the impacts of most of these suspected chemicals are limited due to
the complexities of the hormonal system, the lack of information on the chemicals
themselves and the imprecise route of human exposure. Most of these chemicals are not
having immediate drastic health impacts on the individuals they contaminate. Variations
in the endocrine system in utero can also have extreme impacts on the anatomy, behavior
and prevalence of disease in the developing organism later in life (Vandenbergh, 2004).
These delayed effects have added to the difficultly of scientifically concluding that these
chemicals are problematic.
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These endocrine disrupting chemicals may also be impacting human fertility.
Swan et al. (1997) found a direct connection between poor sperm quality and the general
population’s exposure to endocrine disrupting chemicals. Decreasing sperm counts have
prompted research to determine if chemical exposure could be a potential cause. Carlsen
et al. (1992) did a meta analysis of 61 sperm count studies and claimed that over the past
50 years a significant decline in semen quality has occurred. This result has been
attributed to increased exposure to estrogen, which many of these chemicals mimic, in
utero. Other studies have shown that sperm quality had not declined. Controversy over
infertility and sperm count rates promotes further investigation. Any decline could easily
be attributable to the increased amount of endocrine disrupting chemicals in the
environment.
The rate of many reproductive cancers has also increased in recent years, for
reasons that are largely unknown. Testicular cancer rates are doubling approximately
every 39 years. Cancer rates are continuously dropping among older men but it is still the
most common cancer in young men and has the highest rate of diagnosis among men
between the ages of 30 and 34 (NCI, 2007). Prostate cancer diagnoses have also
continued to rise. Some of this increase is due to better detection, but with increased
incidence there has also been increased mortality; it is now the second most lethal cancer
in men (NCI, 2007). Breast cancer rates have fallen in 2002 and 2003 but it is postulated
that these decreases have been due to reducing the use of hormone replacement therapy
for post-menopausal woman. Breast cancer still remains of the second biggest killer of
American woman. Hypothyroidism is also a condition that impacts over 10 million
people in the U.S (Wood, 2002). This condition can be especially dangerous to pregnant
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woman because thyroid levels of the mother dictate proper brain development in the fetus
(Wood, 2002).
Chemicals can contaminate food, water and air, and be readily inhaled or
consumed by people. Many of the suspected endocrine disruptors are chemicals used as
pesticides, herbicides and fungicides that may leave detectable residues on food.
Chemicals added to common plastics and in other products can contaminate food and
water. Many personal care products such as body lotions and shampoos contain suspected
and known endocrine disrupting chemicals. Many of these chemicals are applied and then
absorbed through the skin and enter the blood stream. After exposure some things are
metabolized in the liver or kidneys, while some are stored in the body or persist in the
bloodstream. An individual’s susceptibility to endocrine disrupting chemicals can vary
greatly due to an individual’s ability to absorb and eliminate chemicals, and their
individual response to endocrine disruptors (Wolff, 2006). Some of these chemicals are
metabolized quickly but may be continuously present in the body depending on to
repeated exposures. This accumulation of toxic chemicals in the human tissue is called a
body burden. Even though chemicals such as DDT and dioxin, potent endocrine
disrupters, are no longer produced in the United States they are still present in our body
burdens now because the actual chemical or the metabolites persist.
The health impacts of continually having these substances in our bodies are
unknown for the majority of endocrine disrupting chemicals. There are limited data that
prove individual endocrine disruptors cause specific health problems. However most of
these chemicals are found in our body burdens. In 2001, the EWG has also examined the
contamination of umbilical cord blood and newborn babies blood. On average 200
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contaminants were found in umbilical cord blood including fire retardants, mercury,
pesticides and a Perflourinated chemical, PFOA, from the manufacture of products like
Teflon™ and Scotchguard™ (Houlihan 2005).
The Centers for Disease Control (CDC) has conducted 3 nationwide biomonitoring studies of body burdens by examining a subset of chemicals or their
metabolites in blood or urine. The Third National Report on Human Exposure to
Environmental Chemicals, the most recent report, measured the prevalence of 148
chemicals in the participants. These chemicals were grouped into metals, cotinines,
dioxins, polycyclic aromatic hydrocarbons (PAHs), furans and polychlorinated biphenyls
(PCBs), phytoestrogens, phthalates, organochlorine pesticides, organophosphate
pesticides, herbicides, pyrethroid insecticides, other pesticides, and carbamate
insecticides (CDC, 2005). This list includes numerous known or suspected endocrine
disrupting chemicals.
A study done by the Environmental Working Group (EWG) found an average of
thirty-five different chemicals in four mother daughter pairs from across the United
States. These chemicals ranged from plasticizers, to stain-proof coating to flame
retardants. Many of the same chemicals found in the mother were also found in the
daughter (EWG, 2006). The EWG also examined the breast milk of twenty first time
mothers in the US and found that the average amount of fire retardants was 75 times
greater than the average determined by a recent study examining European breast milk. A
study done by Foster et al. (2000) examined that amniotic fluid of mothers from Los
Angeles, California. They measured DDT metabolites, the pesticide hexachlorobenzene
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and PCBs. This study concluded that one in three of the fetuses in Los Angeles area was
exposed to these endocrine disruptors in utero.
Body fat is broken down and utilized during pregnancy. Studies are showing that
chemicals stored in fat of the mother are being passed on to the developing fetus. No
matter what a mother does during pregnancy it is inevitable that she will pass to her
children some of these chemicals that she has been storing for her lifetime or because of
her daily exposure to a chemical while pregnant. The “placental barrier” is permeable to
fat-soluble chemicals like many synthetic organochlorines and other chemicals and has
proven not to block the transportation of these chemicals from mother to fetus. This can
be very detrimental to the extremely susceptible fetus, who is rapidly developing and has
limited defenses to combat these toxins.
Many wildlife and plant species have been negatively impacted by endocrine
disrupting chemicals, Table 3 included examples of these animal cases.
Table 3: Examples of endocrine disrupting chemicals and their impacts on wildlife populations (Lathers,
2002) *(AhR, aryl hydrocarbon receptor, DDE, 1,1-dichloro-2, 2-bis (p-chlorophenyl) ethylene; DDT,
dichloro-diphenyl-trichloro-ethane; PAH. Polyaromatic hydrocarbon; PCB, polychlorinated biphenyl)
Species

Site

Observation

Contaminant

Marine

Psuedohermaphroditism, imposex, intersex sterility, population declines

Tributylin

English rivers
Great Lakes

Hermaphroditism, vitellogenin in males, altered testis development
Early life stage mortality, deformities, blue sac disease

White
sucker
Flat fish

Jackfish Bay,
Lake Superior, MI
Puget Sound, WA

Reduced sex steroid levels, delayed sexual maturity, reduced gonad size

Sewage effluent
Dioxin and related
AhR* agonists
Bleached kraft pulp,
mill effluent
PAHs*

Reptiles
Alligator

Lake Apopka

Decreased viability, abnormal gonadal development, decreased phallus
size

DDE*

Global

Egg shell thinning, mortality, developmental abnormalities

DDE

Great Lakes

In ovo and chick mortality, growth retardation, deformities

PCBs, AhR agonists

California

Abnormal mating behavior, supranormal clutch size, skewed sex ratios

DDT* and its
metabolites

Great Lakes

Population decline, developmental toxicity, hormonal alterations

PCBs* and dioxins

Invertebrates
Gastropods
Fish
Trout, roach
Lake trout

Birds
Waterbirds,
raptors
Waterbirds,
raptors
Western
gulls
Mammals
Mink

Decreased hormone levels, reduced ovarian development, reduced
egg/larvae viabilitiy

18

Significant impacts such as morphologic abnormalities, population declines, egg shell
thinning, impaired robustness of offspring and differences in socio-sexual behavior have
been correlated with exposure to endocrine disrupting chemicals (Fox, 2001).
Polychlorinated biphenyls (PCBs) contaminated the Great Lakes in the 1950s and were
likely responsible for causing reproductive abnormalities in the fish and other wildlife in
the area. It was discovered in 1992 that alligators in Florida’s Lake Apoka had severe
reproductive abnormalities, such as shrunken reproductive organs and infertility in males,
likely due to contamination by chemical waste that contained DDT and other
organochlorines (Colburn et. al, 1997). Many of these effects occurred in animals that
were exposed to very low doses of these chemicals.
As mentioned before, many of these chemicals do not readily break down and are
stored in the fatty tissues of the exposed organisms. This allows for the toxins to
accumulate up the food chain or “bioaccumulate.” A study done in Long Island sound
just before DDT was banned found that the chemical’s concentration was .00005 ppm in
the water, .04 ppm in plankton, 0.17-2.07 ppm in fish and 1.07-75.5 ppm in birds
(Woodwell et al., 1967). This is a clear example of how the accumulation of a chemical
can increase as it moves up a food chain in an ecosystem. A well-known example of
detrimental chemical bioaccumulation was in Peregrine falcons who consumed fish
contaminated with DDT. It was discovered that DDT impacted the falcon’s liver ability
to produce an enzyme that maintained the estrogen levels in the birds. This resulted in
thin egg shells with low calcium concentration, which negatively impacted the
offspring’s ability to survive. The U.S. banned DDT in 1972 but due to the continued
persistence of DDT in the environment the population has not yet completely rebounded
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(Wisconsin Dept of Natural Resources, 2007). In 2002, DDT was found in 65% of a
sample of Massachusetts’s homes and 70% of German homes (Rudel et al., 2003, Butte
and Heinzow, 2002). Polychlorinated biphenyls or PCBs are also models of chemicals
that were banned long ago, but are still highly persistent in the environment.
Little information is available on the synergistic impacts of these chemicals on the
body. A study done on amphibians looked at the impact of four herbicides, three
insecticides, and fungicides on the health of frogs as individual contaminants and as a
mixture. The study found that combinations of pesticides had a more severe impact on
the health of the amphibians than the impacts of the individual chemicals. It also showed
that low levels of one commonly used pesticide had more of a detrimental impact on the
amphibian species than when it was exposed to high levels of the same pollutant (Hayes
et al, 2006). Some evidence suggests that endocrine disruptors can have synergistic
impacts when combined with endogenous hormones (Welshons, 2006). This information
is imperative because it is rare that individuals are exposed to only one endocrine
disrupting chemical.
The United States has had limited success in monitoring the impacts of these
chemicals on human health. Historically chemicals have been regulated only after they
have impacted human health, even though we have documented cases, such as lead, of
substances being toxic. DES and DDT are examples of contaminants that were only
eliminated after they did harm. Little human data are available on the toxicity of most of
these chemicals so most conclusions are extrapolated from animal studies. Animal
research is criticized because it cannot be directly compared or applicable to human
health. The endocrine system however is well preserved throughout mammals, so it is
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plausible that impacts on an animal’s endocrine system could have similar impacts on the
human endocrine system. It is standard, according to the EPA when “extrapolating data
from animal experiments to humans, a default value of 10 is typically applied, with a
factor of 3 for differences in toxicodynamics and a value of 3 for toxicokinetic differences.
Unfortunately these uncertainties lead to improper regulation of these chemicals” (EPA,
2005b). This is an example of common “safety” factors that risk assessors use to set
“safe” standards in the absence of proof. Even when standards are maintained, opponents
to research are often able to denounce animal data because it is not totally applicable to
human health. Actions such as these lead to regulation that historically has been too late
to minimize impacts of substances such as lead and DDT.

Current Government Regulation
Regulation of toxic chemicals began in the mid-20th century. In 1947 the first
pesticides were regulated under the Federal Insecticide, Fungicide, and Rodenticide Act,
because their impacts of human health were apparent. Some regulations, such as the
Clean Air Act and Clean Water Act, control some chemical pollutants in the air and
water. Under the 1976 Toxic Substances Control Act (TSCA) the Environmental
Protection Agency is required to collect safety information on all new chemicals. The
burden of proving that these chemicals are detrimental is on the shoulders of the EPA and
thus, the U.S. taxpayer. When this act was created in 1976, over 63,000 chemicals were
grandfathered in and granted approval for their continued use without requiring safety
data (Sharp and Lunder, 2003). Unfortunately only about ten percent of the 82,000
chemicals that are used today in the U.S. have been tested for potential harm and only
21

about a dozen have been restricted because of their toxicity (Duncan, 2006). TSCA is
viewed as a failure and has not been substantially changed in the last 30 years (Hogue,
2007).
Due to TSCA’s regulatory failures the EPA has also initiated the High Production
Volume Challenge Program, which is a voluntary initiative to obtain toxicity information
from manufacturers on the approximately 2,800 chemicals in which more than one
million pounds are produced every year. Programs such as these are innovative but still
voluntary, leaving it up to the chemical manufacturer to determine the health impacts of
their chemicals (Hogue, 2007).
The Federal Insecticide, Fungicide, and Rodenticide Act of 1972 was the first
comprehensive legislation that regulated the distribution, sale and use of pesticides in the
United States. It also developed criteria that required a substance not pose “any
unreasonable risk to man or the environment, taking into account the economic, social
and environmental costs and benefits of use” (EPA, 2003). This Act was amended in
1996 through the Food Quality Act in which safety data must be collected for pesticides
to be regulated; all are subject to re-regulation; exposure of children and effects on health
children’s health are a measure for setting food pesticide tolerances. The standards were
set for pesticide residues in foods, fibers and other crops based “reasonable certainty of
harm.” It requires a 10-fold reduction in tolerance levels for child safety; these tolerances
are reviewed every 10 years. Any of the pesticides that were registered before 1984 were
given an extended 10 years to be properly assessed. These pesticides must be reregistered every 15 years and additional safety testing is required from manufacturers
(EPA, 2003).
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The Emergency Planning and Right-To-Know Act (EPCRA) of 1986 requires the
EPA to collect annual data on the releases and transfers of certain hazardous substances
from industrial facilities and make that information available to the public in a an online
database, the Toxics Release Inventory (TRI). It focuses on 667 chemicals and over
23,000 facilities in the US. Hazardous waste emissions included in the original TRI have
been reduced by 60% since EPCRA was passed (EPA, 2007b).
To respond to the recent increasing risk that pesticides and other chemicals pose
to the endocrine system, the Endocrine Disruptor Screening and Testing Advisory
Committee or EDSTAC was established in 1996. This federal advisory committee spent
two years developing recommendations to the EPA for proper screening and testing of
endocrine disrupting chemicals. The committee successfully created protocols for 14
assays, or screening programs, to provide the EPA with the information needed to make
regulatory decisions about the effects of chemicals on the endocrine system (EPA,
2007a). Each of these assays, however, needs to go through a comprehensive testing
program to confirm viability. After nearly 10 years, this testing has not occurred, due
mainly to lack of funding. The total budget allotted for 2003-2005 was only $15 million
dollars for independent research to be done on endocrine disruptors (EPA, 2007a).
EDSTAC is a promising starting point for endocrine disruptor testing but it needs
considerable support from the government to be successful. Professor Joel Tickner, a
Professor in the Department of Community Health and Sustainability at the University of
Massachusetts-Lowell claims that:
“our chemical industry and our government risk being marginalized in a
global market that is increasingly concerned about the health and
environmental implications of industrial substances. It is time for industry
and the federal government to acknowledge the benefits of a renewed

23

chemicals management structure. Only then can we being to map the path
toward designing and implementing safer, more sustainable chemistry”
(Hogue 2007).
Tickner was interviewed in a Chemical and Engineering News point/counterpoint article
with Michael P. Walls, managing director of the American Chemistry Council who
claimed that TOSCA was a comprehensive and adequate chemical monitoring program
(Hogue, 2007). The article is an example of industry favoring less regulation, which is
less expensive, while the scientific community pushes for more regulation and testing
when the impacts on health are unknown.
The expressed “aim” of American toxic regulation has been for exposures to
harmful products be 1,000 to 3,000 times lower than the levels that cause harm in
laboratory animals (Fischer, 2007). Without proper information on the toxicities in
animals, there is no way to meet this standard. Much of our regulations require the
identification of a “safe” threshold, but it is becoming increasingly clear that threshold is
safe for endocrine disruptors.
The chemical lobbies are very profitable and are very active in Washington and
have historically been able to devalue independent data by use of data from their studies.
Regulation dictated by industry funded science can lead to bias that overlooks the welfare
of the exposed population in favor of maintaining profit. A new study done by the Center
for Public Integrity found that 71 out of the top 100 Superfund polluters and responsible
parties spent more than a billion dollars lobbying in Congress from 1998-2005
(Narayanswamy, 2007).
The European Union has adopted the a new regulatory program called REACH
(Registration, Evaluation and Authorization of Chemicals) which puts the burden on
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chemical companies to assure that their products are safe or that the benefits are greater
than any of the incurred risk. It requires testing of new and old chemicals, which
eliminates the problem of grandfathering. It also recommends that chemical companies
develop safer alternatives to harmful chemicals to support the green chemistry industry.
REACH was a compromise reached between concerned individuals and environmental
groups and governments who wanted tougher regulations and industry (European
Commission, 2007).
REACH is based on the precautionary principle that states that if an action or
policy may cause severe or irreversible harm, in the absence of a scientific consensus, the
policy should air on the side of caution. A precautionary approach would take sound
animal toxicity data and use it to make decisions about chemicals without sound human
toxicology data. The United States does not use this approach while other bodies, such as
the European Union, have used precaution when regulating potential toxics.

My Project
With a purchasing budget of more than a million dollars a year, Colby’s
purchasing choices can have a significant impact on the environment and health of the
Colby community. Colby prides itself as being environmentally conscious institution but
it is likely that Colby purchases certain things that may pose health risks, which are
unknown to the majority of the public. My project aims to evaluate and synthesize the
scientific literature on five endocrine disrupting chemicals and use that information to
construct a scoring system for assessing the endocrine health threats posed by these
chemicals.
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METHODS
Comprehensive Review of the Literature
The first part of my thesis is a comprehensive literature review. First I examined
the general information on endocrine disrupting chemicals and isolated specific
chemicals that members of the Colby community may be exposed to and chemicals that
have existing toxicology research. All of the research is accrued from past peer reviewed
scientific research and periodicals, but because endocrine disruption is such an emerging
field, few review articles exist. I decided to focus on five chemicals, bisphenol-a,
phthalates, parabens, brominated flame retardants and perfluorinated chemicals. All of
these chemicals are commonly used throughout the United States and in some products at
Colby.
Health Impact Scoring
I created a scoring system that can be used to assess the potential health impacts
of certain chemicals that can be in certain products and purchased by individuals and
institutions, such as Colby. The mechanisms in place to adequately assess the harm of
chemicals such as endocrine disruptors is very complicated and outdated. Many in the
scientific and regulatory community have realized that looking at data such as the lowest
toxic dose and ignoring synergistic impacts of chemicals is not adequate. There are often
data gaps, uncertainty, even lack of a consensus on what counts as viable evidence and
how to quantitate evidence. In 2005, the EPA recognized that the current process used to
determine the risk of carcinogens was indeed outdated and insufficient. A report in March
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of that year stated that the protocol needed to be expanded because of the complexities of
the problem. They included a weight of evidence analysis, which took into account the
uncertainty of data concerned with carcinogenic chemicals. They also determined that it
was essential to look at the synergistic impacts of these chemicals and the impacts on
children more closely (EPA, 2005a).
My score includes the information gathered through the literature review and
other factors, such as uncertainty of data, which the EPA now recognizes is an important
factor in health assessments. My final conclusions act as a piece of a health impact
assessment concerning these potentially harmful chemicals. Health impact assessments
use the “best available evidence to assess the likely effect of a specific policy in a specific
situation” (Mindell, 2004). Identifying the aspects of a policy/product that may impact
health and those health outcomes are essential to reach a thorough decision. The World
Health Organization (WHO) has identified Health Impact Statements as a way to reach
accountability for health and set a target for Europe to establish mechanisms for HIAs by
2020. Figure 4 below shows the different levels of analysis that are needed in a health
impact assessment and how these can be translated into examining the health impacts of
Colby’s purchasing practices. The policy choice of serving caffeinated soda in the dining
hall is an example as seen in Figure 4.
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Ex. Colby serves caffeinated soda in the dining
hall

Policy/ Practice

1
Health Determinants

Sugar intake (-)
Caffeine intake (- or +) *
Increased hydration (+)

2
Health Outcomes

Hydration (+)
Blood sugar fluctuation (- or +)
Dental health (-)
Impacts of caffeine (- or +)*

3
Summary Measure of Public
Health Impact

The risk of negative health outcomes from
caffeinated soda consumption in the dining halls
does not outweigh the benefits of having these
beverages available

Figure 4: Represents the steps necessary to conduct a proper health impact assessment with examples of
how this could be applicable to Colby purchasing practices.

My report does not attempt to look at every possible health impact of the products used at
Colby. In this example I would only be interested specifically in step 2, the asterisked
parts of the assessment. My project only looks only at the identification and human health
impacts of the endocrine disrupting chemicals that the products may contain. The
summary measure examines how health determinants of certain products Colby
purchases could affect human health outcomes. This is just one part of a larger
assessment that could be done on the impact of numerous environmental policies and
activities on our lives, including determinants at Colby.
Health impact assessments have limitations, such as the availability of valid data,
the availability of methods to quantify health effects, the uncertainty due to the end result,
being seldom explicit, and defining standards for what counts as suitable indicators of
public health. Despite these flaws, these assessments have recently begun to be
incorporated into environmental impact assessments, especially as mentioned before by
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the WHO. An important aspect of these health assessments is that they have built into
them a pragmatic need to inform policy makers using the “best available evidence.”
The actual quantitative measurement done in health impact assessments can vary based
on the information available. Due to the inherent limitations of health impact assessments
there are rarely hard statistical data to analyze. Policy makers have to be creative when
examining data that often can be qualitative.
A health impact study done by the Edinburgh Council’s Urban Transport Strategy
used a system of pluses and minuses to evaluate the health impacts of two potential
transport policy scenarios. Scenario 1 dictated decreased spending on the transportation
system while scenario 3 called for an increase in spending on transportation. It was first
determined if these scenarios would change the number of accidents, amount of pollution
and physical activity, the access to good and the community network and then how those
changes would impact community health. Table 4 is a selection from the matrix that
looks at the impacts of the two scenarios on economically deprived and affluent
adolescents. This matrix uses symbols to represent very positive to very negative impacts,
which are fairly subjective ways to classify health impacts.
Table 4: Matrix showing the health impacts of adolescents population groups under transport policy
scenario 1 and scenario 3. Key: ++, very positive impact; +, positive impact; 0, no impact; -, negative
impact; -- very negative impact. (Scottish Needs Assessment Programme, 2000)

Accidents
1

3

1

3

1

3

Access to
goods
and services
1
3

Affluent

-

++

--

+

-

+

--

++

--

++

Deprived

--

+

-

+

-

++

--

++

--

++

Scenario

Pollution

Physical
Activity

Community
Network
1

3

Adolescents

29

Instead of pluses and minuses my score uses a numerical scale ranging from 1-3,
3 being the most detrimental to human health. The score will take into account the
likelihood of exposure, the level of exposure, the health impact at that level of exposure,
the health impact at the maximum level of exposure (if definable), severity of health
impact, reversibility of health impact and the uncertainty of the data that are available.
The score will be an average of four separate categories: scale, severity of health impacts,
persistent exposure, uncertainty, Table 5 illustrates the scoring of each of these
chemicals.
Table 5: Illustration of my scoring method for different categories.
Category
Scale

Score

Explanation

1

Limited exposure to pollutant and health effects impacting limited number of
people
Moderate exposure to pollutant and health effects impacting moderate number
of people
Majority of population are exposed to pollutant and impacts large portion of the
population

2
3
Severity of Health
Impacts
1
2
3

Health impacts are negligible and easily treatable.
Health impacts moderately impact the individual more than one system can be
impacted.
Health impacts are severe, there are multiple different effects, irreversible
impacts.

Persistent Exposure
1
2
3

Chemical is not present in the body and environment
Chemical is moderately present in the body and environment
Chemical is constantly present in the body and environment.

1
2

Limited research available, ample uncertainty about impacts on health
Moderate amount of quality data available to support existence of negative
health impacts
Large amount of consistent, repeated research that supports the existence of
negative health impacts

Uncertainty

3

As seen in Table 5, “scale” will be scored from 1-3, 1 indicating that there is
limited exposure to the population of this chemical, while 3 would indicate that the
majority of the population is exposed to this chemical. This will be determined by
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analyzing the products that contain the chemical and the exposure of the population to
these products.
“Persistent exposure” of these chemicals will be based on the lifecycle of the
chemical and the degree of its existence in the body and/or the environment. The score
will consider the accumulation and presence of the chemicals in the human body and
environment. A low score would indicate that the chemical does not accumulate and is
not present in the body or the environment while a high score would indicate that the
chemical is present in the human body for a considerable length of time. This is important
when we consider the case of DDT, whose use has been banned for decades, and yet we
still ingest DDT metabolites in our food due to the chemical’s persistence. Many of these
chemicals do not persistent in the body but constant low levels can exist because of
continuous exposure. This continuous exposure can facilitate an increased “persistent
exposure” of these chemicals in the body.
“Severity” of health impacts will be based on the health implications of exposure
to this chemical. Impacts that can directly impact one’s lifespan such as cancer would
increase the score of the chemical in this area. Reproductive impacts and impacts on
development would be examples of health impacts that would be categorized as severe
and would receive a higher score.
“Uncertainty” will be based on the quantity and quality of the information that is
available on the chemical. There may be limited toxicology or epidemiological research,
and it is difficult to determine causality in humans. The health impacts of some
chemicals are more certain than others. A low score in this area would mean that there is
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significant uncertainty about the health impacts of the chemical while a high score would
indicate that there is ample repeatable data on the toxicology of the chemical.
The scores from each of these categories are then averaged to determine a
cumulative score for each chemical. Each category is equally weighted and just as in the
in the individual categories the final score ranges from 1 to 3. Uncertainty, though unlike
the other categories, is equally weighted because research available is limited and new
information is constantly emerging. Also the literature provides no precedents suggesting
that the categories should be weighed any differently.
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RESULTS
Review of Health Impacts of Endocrine Disrupting Chemicals
Bisphenol-A (BPA)
Bisphenol-a (BPA) is a synthetic plastic monomer used in high volumes
worldwide. In its raw form BPA it is a gray powder and has a chlorophenol-like odor. It
originally developed to be a synthetic estrogen in the 1930’s, was never used medically
and was introduced into the industrial sector in the 1950s. It is a monomer for production
of engineering plastics (polycarbonate/epoxy resins) and is used in dental
composites/sealants and the lacquer coatings of food cans. It also is used in the
production of tetrabromobisphenol-a, a flame retardant, aromatic polyesters with pthlalic
acid, polyeterimide, polyarylate resins, polysulfones and antioxidants. Figure 5 shows the
chemical polymerization of BPA, which has a chemical formula of C15H16O2 or
(CH3)2C(C6H4OH)2, into polycarbonate. BPA polycarbonate plastic is highly desirable

Figure 5: The chemical polymerization of bisphenol-a into polycarbonate.
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because of the plastic’s durability, increased transparency, compatibility with multiple
polymers and its resistance to high heat. It has been used to produce everything from
compact disks to housings for cellular telephones to baby bottles and Nalgene™ water
bottles (Tsai, 2006).
Large industries such as the electrical and automobile industries heavily use BPA
for high grade polycarbonate, and the industrial demand for BPA has rapidly increased in
recent years. Approximately one third of the total amount of BPA is produced in the
United States, while several new plants are being built in Asia to meet the growing
demand for polycarbonate plastic in growing Asian economies (Tsai, 2006). In the United
States, in 2002, BPA production amassed $5.3 billion dollars in profit (Daly, 2006)
The extent of BPA’s estrogenic activity has been examined in the lab as compared
to estradiol. When looking at dose multiplied with potency BPA achieves a 1. BPA is
much less estrogenic than the morning after pill or the birth control pill, but more
estrogenic than organochlorines, which historically have been shown to impact the
endocrine system severely.
One of the biggest challenges in looking at endocrine disruption in the lack of
comprehensive health data. The Human Toxome Project is a compilation of body burden
studies on multiple different chemicals. It examines the amount of research available to
support toxicology impacts of various chemicals, including BPA. It’s compiled by the
Environmental Working Group and Commonweal, both nonprofit health and
environmental research institutes. Table 6 is a summary of health impact research that is
available on BPA and the quality of that evidence. This table looks to the weight of
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evidence that is available concerning BPA’s impact on the body’s systems. The better the
evidence, the more certain scientists can be that a BPA causes specific health problems.
This scale takes into account the amount, type, and quality of evidence. The scale ranges
from data labeled as “limited” to “probable” information available to “strong”
information to “known” information.
Table 6: A summary of the amount of available health information available on BPA. (EWG, 2007b)
Top health concerns for BPA
Health Concern or Target Organ
Hormone Activity
Skin
Other health concerns for BPA and BADGE
Immune system (including sensitization and allergies)
Cancer
Sense Organs
Reproduction and Fertility
Birth defects and developmental delays
Kidney and renal system
Persistent, accumulates in wildlife and or/people

Weight of Evidence
strong
limited
known
limited
limited
known
limited
limited
probable

As mentioned earlier, human studies offer the best information but this is unfortunately
limited for many of these chemicals, including BPA. According to the EPA “when
relying on animal studies only, scientists need to be satisfied that health effects in humans
are likely to be the same as those in the animals tested” (EPA, 2005a). This is fitting for
endocrine disrupting chemicals because the endocrine system varies minimally between
species.
As seen in Table 6 in which the health effects tied to the endocrine system are
italicized, “strong” and “known” information is available on the impacts the chemical has
on hormone activity and reproduction and fertility, while it classifies the information
about birth defects and developmental delays as “limited.” As with my scale this weight
of evidence method is a fairly qualitative measurement because of the complexities of the
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research and is only one piece when analyzing the toxicity information that is available
on a chemical.
The imperative piece of information about the toxicity of BPA is that extremely
low levels can have a significant impact on health. In 1993, a research team from
Stanford reported that BPA can exhibit estrogenic activity even when it exists in
quantities as small as parts per billion (Raloff, 1999). Vom Saal (1998) also found that
exposure of male mice exposed to just 2 ppb resulted in an enlarged prostate. Another
study found a decrease in fertility and daily sperm production in mice when they were
exposed to low doses of BPA (Kawai et al., 2003). Many of the health effects on
offspring are caused by exposure to BPA during gestation and/or lactation, but some
impacts have been reported from early development through adulthood (vom Saal and
Hughes, 2005).
In a literature review conducted by vom Saal (2005), he concluded that low doses
of BPA impacted the rate of growth, sexual maturation, reproductive organ function,
hormone levels in blood, fertility, immune function, enzyme activity, brain structure and
chemistry, and behavior. Tsai (2006) conducted a similar overview of the human health
risks of environmental exposure to BPA in 2006 and concluded that it is essential to
restrict the releases of this estrogenic chemical when taking into account its ecotoxicity
and impact on human health. He found that BPA should not pose a carcinogenic risk to
humans based on the available data. However he did recognize the estrogenic activity of
the chemical, which has impacted developing fetuses, impaired sperm production,
enhanced cell proliferation in the a breast cancer cell line, altered the onset of sexual
maturity and changed male reproductive organs (Tsai, 2006).
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Small amounts of BPA have been shown to leach from products and into the food
or water supply. The most significant route of human exposure is from the ingestion of
BPA in canned foods lined with epoxy resins, ingestion and absorption of saliva in
contact with dental sealants, and intake of water stored in polycarbonate bottles (Tsai,
2006). Studies show that BPA leaches from dental sealants and from polycarbonate
plastic water bottles and baby bottles (Tsai, 2006). Arizono, a researcher from the
University of Kumamoto, tested 10 different brands of baby bottles, from all over the
world, including the United States. When these bottles were heated, all of them leached
detectable levels of BPA (Raloff, 1999). He also compared the amount of BPA that
leached out of new baby bottles versus bottles that were heavily worn and scratched.
Water in the new bottles contained 1 to 3.5 parts per billion of BPA. These same bottles
when heated picked up 6.5 ppb of BPA. The water in older more scratched bottles
contained between 10 and 28 ppb of BPA (Raloff, 1999). BPA has also been detected in
indoor and outdoor air and in floor dust (Tsai, 2006). This shows that populations can be
exposed to BPA through air, soil, diet, and from water sources. According to toxicology
data some of these detected levels exceed concentrations that have had negative impact in
vitro.
A study done by Howe and Borodinsky (1998) showed that bisphenol-a leached
from the coatings of food cans and contaminated the stored food. Researchers at the
University of Granada analyzed food cans lined with resin containing BPA and found
that more than half of the cans that were analyzed had measurable amounts of the
contaminant (Raloff, 1999). A recent study by the EWG found that in over 97 cans that
were tested more than half of the contents of the cans had detectable amounts of BPA that
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had leached out of the can’s lining. Table 7 represents the amount of BPA found in a
random selection of canned food.
Table 7: Environmental Working Group results of BPA contamination of canned foods (EWG, 2007a).

All foods
Beans

Number
of brands
tested
30
3

Number of
cans
tested
97
6

Fruit

6

17

Infant formula

2

6

2

5

2
2
5

3
6
12
19

2
8

6
17

Canned
Foods

Meal
replacement
Milk products
Pasta
Soda
Soup
Tuna
Vegetable

% of
samples
with BPA
57%
83%

Average BPA
level and range
(ppb)
7.9 (ND - 385)
9.7 (ND - 38)

35%

2.3 (ND - 27)

33%

2.4 (ND - 17)

liquid meal replacements

40%

4.2 (ND - 66)

evaporated milk
ravioli, spaghetti
cola, diet cola
beef stew, chicken noodle,
chicken rice, chicken
vegetable, tomato, vegetable
chunk lite, solid white
corn, green beans, mixed
vegetables, peas, tomatoes

66%
100%
42%
89%

3.5 (ND - 9)
63.5 (16 - 247)
1.7 (ND - 8)
57.6 (ND - 385)

50%
41%

9.6 (ND - 108)
7.8 (ND - 330)

Foods tested

baked beans
mixed fruit, cranberry sauce,
peaches, pears, pineapple
concentrated infant soy and
milk-based formula

In all canned food products some samples had detectable BPA. Twenty of the
forty most consumed canned food were tested in this study. These included soda, canned
tuna, peaches, pineapples, green beans, corn and tomato and chicken noodle soup (EWG,
2007a). This is imperative information because the Food and Drug Administration
estimates that 40% of American’s diet comes from canned foods (EWG, 2007a). There
have been negative impacts reported in animal studies that resulted from a daily exposure
of only 2 ppb of BPA. As seen in Table 7 all but one of the examined canned products
had levels higher than 2 ppb of BPA.
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Pulgar et al. (2000) noted that BPA leached into saliva collected an hour after
treatment of dental treatments administered to children to prevent cavities. In once
instance BPA was detected in a child’s saliva 2 years after it was applied.
Few studies focus on the concentrations of BPA in the air. Wilson et al. (2001)
studied the US field measurement of persistent organic chemicals (including BPA) in
indoor and outdoor air and found significantly more BPA in indoor air samples. This
suggests that BPA in common household products and furniture is contaminating the air
(Tsai, 2006). Multiple studies have also detected BPA in the effluent of municipal and
industrial wastewater treatment plants (Tsai, 2006). Tsai deciphered from examining
these studies that concentrations in the water bodies are at such low concentrations that
they do not pose a threat. He also concluded that the water leaching from landfills has
considerably more BPA than in water bodies without landfill water inputs. It was also
found that areas in Asia, which were close to BPA production sites, had elevated
concentrations of BPA in the water (Tsai, 2006).
BPA is biodegradable and poses a low to moderate potential to bioaccumulate in
microorganisms, algae, fish, invertebrates in the environment (Staples et al., 1998). It is
also considered to have low mobility in soils because it easily adsorbs into environmental
phases that are rich in organic matter (Tsai, 2006). A study done by Calafat et al. (2005)
reported that 95% of the Americans tested had BPA in their urine. Despite the fact that
BPA biodegrades, its prevalence in the environment leads to chronic human exposure;
newly exposed BPA is constantly replacing degraded BPA that has already contaminated
the body.
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When BPA enters the body it combines readily with sugars already in the system.
These sugars are then excreted readily through the body taking the BPA with it. BPA is
not a fat soluble chemical, like many other persistent chemicals, which allows it to pass
through the body and environment quickly.
The European Union and the United States have set a limit of 0.05 mg/kg bw/day
or .05 ppm per day as an acceptable daily intake (Tsai, 2006). However researchers have
determined that due to the many unknowns about BPA it is imperative to continue
research. The current regulation is based on old research that does not take into account
the new evidence on the low dose impact of BPA. No government regulation controls the
amount of BPA that leaches out of polycarbonate plastics and canned food linings, unlike
in Europe and Japan. Due to this discrepancy people may be exposed not only to low
levels of BPA, but potentially higher than the current set “safe” level. Vom Saal and
Hughes (2005) recommend that a new lowest observed adverse effect level must be taken
into consideration due to the evidence of impacts of low doses of BPA on the systems of
snails, fish, frogs and mammals. They concluded that of the 115 in vivo published studies
concerning the low-dose impacts of BPA, 94 of them reported significant effects. Ninety
percent of government funded studies have reported significant impacts (vom Saal,
2005). Chemical companies, however, continue to discount these impacts because no
industry funded studies have shown any significant impacts. The US Congress became
especially concerned in March of 2007 because it was discovered that a National
Toxicology Program’s health report for BPA is being compiled by a contractor with ties
to chemical companies that produce BPA (Hileman, 2007).
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Under the Emergency Planning and Community Right to Know Act (EPCRA) it
is required to report if a form of BPA, tetrabromobisphenol-a, is released into the
environment (EPA, 2007b). It is on the burden of the EPA to determine what chemicals
are safe. Multiple tolerable daily intake levels have been set for BPA. Over the years
these levels have continuously decreased as more is known about the impacts of exposure
to low levels of BPA.
Phthalates
Phthalates are a group of synthetically manufactured chemicals that are
commonly used in plastics and in other common consumer products. Like BPA they have
many beneficial chemical properties and about a billion pounds of are produced per year.
They are used as softeners in plastics, and as additives in personal care products and
construction materials. It is difficult to find a personal care product that is void of
phthalates and there are at least five different kinds that are present in cosmetic products.
Table 8 is taken from an EWG report titled “Not Too Pretty: Phthalates, Beauty Products
and the FDA” that examined phthalates in personal care products.
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Table 8: Results of testing 72 different personal care products for five different types of phthalates
(Houlihan, 2002)
Percent of products tested
or surveyed that contain
this phthalate (and
number of products out of
the 72 products tested)
All phthalates
tested

72 percent (52 products)

Diethyl
phthalate (DEP)

71 percent (51 products)

Dibutyl
phthalate (DBP)
Dibutyl
phthalate (DBP)
Butylbenzyl
phthalate
(BBzP)
Diethylhexyl
phthalate
(DEHP)
Dimethyl
phthalate
(DMP)

67 percent*

Types of products
Deodorant, fragrance, hair
gel, hair mousse, hair
spray, hand and body
lotions, nail polish
Deodorant, fragrance, hair
gel, hair mousse, hair
spray, hand and body
lotions
Nail polish

Average
concentration
from all positive
test (ppm)

Maximum
concentration
found (ppm)

4070

28,000 (or 2.8
percent)

50,000 (or 5
percent)

N/A

8 percent (6 products)

Deodorant, fragrance, hair
spray

275

890

6 percent (4 products)

fragrance

14

46

4 percent (3 products)

Fragrance

11

25

1 percent (1 product)

Deodorant

33
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This table shows that 2 out of the 5 phthalates are found in the majority of the personal
care products that were tested. The average concentration of these forms of phthalates
ranged from 14 to 50,000 ppm. As seen above these chemicals are detected in cosmetics,
perfumes and lotions, as plasticizers and solvents for cellulose acetate, and also are used
in the production of varnishes, lacquers and coatings, including some used to make time
release pharmaceuticals (Hauser et al., 2006). A study done by A. Afshari et al. (2004)
determined that when plasticizers are used in surface flooring materials, phthalates are
detectable despite ventilation. The fragrance that is emitted from car air fresheners for
example is also caused by the volatization of phthalates. Many of the plastics with added
phthalates are used for small children’s toys and even pacifiers have added phthalates.
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People can be exposed to phthalates through the use of products that contain
phthalates, through inhalation of dust that is contaminated with phthalates, receiving a
medical treatment, such a dialysis or a blood transfusion, that uses equipment made of
plastics with added phthalates or by living near to a facility that manufactures products
containing phthalates.
Phthalates are chemically dialkyl or alkyl aryl esters of 1,2-benzenedicarboxylic
acids. There are many different types of phthalates in production and in turn multiple
associated toxicological properties. Diethylhexl phthalate (DEHP) and dibutyl phthalate
(DBP) are two of the most commonly used phthalates, which are most toxic.
Considerable health research has been done on the phthalates and Table 9 is a summary
of the health concerns associated with phthalates and the certainty of the health data
compiled.

Table 9: A summary of the amount of available health information available on phthalates. (EWG, 2007b)
Top health concerns for Phthalates
Health Concern or Phthalates
Reproduction and Fertility
Birth defects and developmental delays
Hormone Activity
Other health concerns for Phthalates
Immune system (including sensitization and allergies)
Skin
Sense Organs
Gastrointestinal (including liver)
Persistent, accumulates in wildlife and or/people
Cancer
Respiratory System
Brain and nervous system

Weight of Evidence
strong
strong
strong
known
limited
limited
limited
probable
limited
known
strong

As seen in the table above the top health concerns defined for phthalates are also
endocrine related health problems. Reproduction and fertility, birth defects and
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developmental delays and hormone activity were all top concerns that were classified as
having “strong” research available to support the health impacts of these chemicals.
Phthalate monoesters, mainly monoethylhexyl phthalate and monobutyl phthalate, are
known to be reproductive and developmental toxicants in animals (Hoppin et al., 2002).
Phthalates estrogenic activity as compared to estradiol is less than .0000010, which is
weaker than the estrogenic activity of DES and BPA (Wolff, 2006). It is still important to
recognize that phthalates have detectable estrogenic activity.
Cancer and adult infertility in rats result from high doses of phthalates (Colburn et
al., 2007). DEHP has been shown to suppress the female hormone estradiol and impact
ovulation cycles in rats (Davis et al., 1994). DBP has shown to cause testicular toxicity
and impair uterine function, which has led to fetal death in rats (Zacharewski, 1998)
Research concerning low doses has shown to interact with the male androgen receptor
which results in multiple detrimental impacts on the developing male reproductive tract
(Hobel et al., 2005). Hypospadias increased by more than fifty percent in mice whose
mothers were exposed to diethylhexyl phthalate (DEHP) and Gray et al. (1999)
determined that the testes were directly targeted by the DEHP during development. This
research is important because it looked at doses of phthalates that were previously
thought to be far below the level of “concern.”
Andrade et al. (2006) wrote an important paper in 2006 which showcased “the
non-monotonic dose-response” (NMDRC) curve exhibited by rat brain activity to varying
doses of phthalates. The NMDRC contradicts traditional toxicology practice based on the
idea that the “dose makes the poison.” It proves that toxicity responses can be shaped as a
U, in which the most detrimental impacts can occur at low or high doses. The curve can
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also be shaped as an inverted U, in which that intermediates amounts of an endocrine
disrupting toxin can have more serve impacts than low or high doses. Andrade’s research
showed that low doses of DEHP can have more detrimental impacts on the
masculinzation of a rat brain than higher doses. Most importantly this research proves
that measuring responses at high doses is not always a valid way to determine the impacts
of a chemical (Andrade, 2006).
Swan et al. (2005) discovered a highly significant relationship between exposure
of a mother to phthalates during pregnancy to the reproductive development of her male
offspring. These offspring developed smaller male reproductive tracts, which was
synonymous with lower penis volumes and hypospadias (Swan et al., 2005). This study
builds on a large number of animal studies that showed a cluster of reproductive impacts
called ‘the phthalate syndrome.’ This syndrome, in addition to hypospadias and
impairment of the male reproductive tract, resulted in lower sperm counts and testicular
tumors in adulthood (Colburn et. al, 2007).
Another study published in Environmental Health Perspectives linked phthalate
exposure to a lowered sensitivity to insulin and an increased risk of obesity in men
(Stahlhut et al., 2007). Three studies in 2002 and 2003 showed that background phthalate
exposures caused reductions in semen quality. Duty et. al. (2003) showed that normal
phthalate levels of MEP, a type of phthalate, damaged sperm DNA in a group of Boston
men, while two other studies showed that found reductions in sperm quality of men that
had highly elevated phthalate levels (Colburn et al., 2007).
Concern over phthalates resulted in a panel convened by the National Toxicology
Program to review the scientific evidence about the potential harm of phthalates. Despite

45

the limited amount of research available at that time, the Panel concluded that DEHP
should be of serious concern. This was due primarily to the evidence that DEHP damages
Sertoli cells during development, which can impact the reproductive health of males later
in life and lower sperm count (Colburn et al.. 2007). The other three phthalates (diisononyl phthalate, di-n-butyl phthalate and di-n-octyl phthalate) that were examined
were assigned “low, minimal or negligible concern” by the panel (Colburn et al.. 2007).
The National Institute of Occupational Safety and Health also reviewed phthalates and
classified DEHP as a high priority chemical for further study because of its ubiquitous
nature and its toxic impacts on reproductive systems in animal studies (Moorman et al.,
2000).
The biologic half-life of these monoesters is about 12 hours, in turn, phthalates
can be excreted from the body after approximately 12 hours after absorption. The
ubiquitous nature of this chemical and constant human exposure allows the chemical to
maintain a constant presence in our bodies. A study done on 46 women living in
Washington, DC found that they had the same concentration of four phthalate monoesters
in their urine on two different sampling days (Hoppin et al., 2002). As mentioned earlier
the CDC’s Third National Report on Human Exposure to Environmental Chemicals
found widespread exposure to phthalates with the levels being highest in children and
women of reproductive age, which can pose serious developmental risks (CDC, 2005).
The same report CDC found the two most common cosmetic phthalates was in almost all
of the 2,782 people examined (Wolff, 2006). Swan et al. also concluded that
approximately 25% of the Americans studied by the CDC had body burdens of phthalates
large enough to theoretically have an impact on the male reproductive tract.
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The Agency for Toxic Substances and Disease Registry monitors DHEP release
into the environment mainly through industrial site exposure to educate the public on
where DHEP may be and the potential impacts of large doses of DHEP can have on
health (ATSDR, 2001). The California Safe Cosmetics Act of 2005 is a monumental
piece of legislation that requires any manufacturers that sells over a million dollars per
year of personal care products to report any products that contains a chemical that is a
reproductive or developmental toxin or carcinogen. DBP and DEHP are two phthalates
that are included in this list. The state plans to post this list in hopes to increase
consumer pressure to eliminate these chemicals from these products (Wolff, 2006).
European regulators have tackled the phthalate problem by calling for a phase-out
of DEHP from toys and certain medical devices. In response, the US Consumer Products
Safety Commission called for a voluntary phase-out of DEHP from these same products.
Many significant toy manufacturers such as Mattel and Disney agreed publicly to
eliminate phthalates from their products.
Cosmetics and body care products contain many unlisted phthalates. In response
to the research on phthalates, the EU has outlawed phthalates from personal care products
in addition to over a thousand other chemicals (Pitman, 2006). The United States has only
outlawed only eight, not including phthalates. No mandate in the United States requires
safety data for cosmetic ingredients. In response however to consumer pressure,
companies such as Essie, OPI, Avon, Cover Girl and Estee Lauder have worked to limit
phthalates in their products. In total around 380 U.S. companies have signed the Compact
for Global Production of Safe Health and Beauty Products, which acts as a voluntarily
pledge to manufacture products that abide by the EU safety standards (Wolff, 2006).
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Polybrominated Flame Retardants (PBDEs)
Polybrominated diphenyl ethers (PBDEs) have been added to multiple products
over the years to make products less flammable. The three main types are
decabrominated diphenyl ethers (deca or deca-bdes), octabrominated ethers (octa or octabdes) and pentabrominated ethers (penta or penta-bdes). The delineation of penta or octa
or deca depends on the number of bromines in the chemical structure. Figure 6 is a
diagram of the different chemical structures of PBDEs.

Figure 6: Chemical makeup of PBDEs (EWG, 2003)

This diagram also showcases the many different forms of the three different chemicals.
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Electronics equipment, lighting, building materials, textiles and furniture are all
examples of the thousands of products that are treated with PBDEs, table 10 illustrates
the vast number of products that contain PBDE. These chemicals are used throughout the

Table 10: Represents the multiple products in which PBDE’s are used, bold indicates a major use (Sharp
and Lunder, 2003).
Materials
used in
Plastics

Examples of Consumer Products
Deca
X

Polyurethane
foam
Textiles
Paints and
Lacquers
Rubber

Octa
X

Penta
X

X
X

X

X

X

X

X

Computers, televisions, hair dryers, curling irons, copy machines,
printers, coffee makers, plastic automotive parts, lighting panels,
PVC wire and cables, electrical connectors, fuses, housings, boxes
and switches, lamp sockets, waste-water pipes, underground
junction boxes, circuit boards, smoke detectors
Home and office furniture (couches and chairs, carpet padding,
mattresses and mattress pads) automobile, plane, bus and train
seating, sounds insulation panels, imitation wood and packaging
materials
Back coatings and impregnation of home and office furniture
upholstery, industrial drapes, automotive, aircraft and train seating.
Marine and industry protective lacquers and paints.
Conveyor belts, foamed pipes for insulation, rubber cables.

World, but most intensely in the United States, in which 149 million pounds were used in
2001 (Sharp and Lunder, 2003). Deca is the most commonly used type of PBDE and
makes up 83% of the global market for these chemicals and 74% of the US market
(BSEF, 2000)(Tullo, 2003). Deca is primarily used in the plastics casings of electronic
equipment such as televisions, office machines and computers. It is also used for plastic
auto parts, electrical connectors, fuses and lighting panels (Sharp and Lunder, 2003).
The toxicology data on the health impacts of PBDEs is constantly emerging.
Table 11 below is an overview of the certainty of the available information for the
different health impacts potentially associated with PBDE exposure. One of the top
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Table 11: A summary of the amount of available health information available on PBDEs (EWG, 2007b).
Top health concerns for PBDEs
Health Concern or Target Organ
Reproduction and Fertility
Brain and nervous system
Other health concerns for PFCs
Persistent, accumulates in wildlife and or/people
Cancer
Birth defects and developmental delays
Hormone Activity
Gastrointestinal (including liver)

Weight of Evidence
strong
strong
probable
limited
probable
known
limited

health concerns for PBDEs were categorized by the Human Toxome Project was impacts
on reproduction and fertility, in which “strong” information is available. The hormone
activity associated with PBDEs is classified as being “known” while the research on the
impacts of PBDEs on birth defects and developmental delays is of “probable” certainty.
Deca was previously thought to only be toxic at very high doses. One single study
in 1986 found that high doses of Deca caused thyroid, liver and pancreas tumors in rats
and mice (NTP, 1986). In vitro studies PBDE’s, has been shown to negatively impact
motor skills, memory and hearing and change behavior when mice are exposed to PBDE
at critical development times. Exposures to PBDEs have had negative impacts on thyroid
levels and the neurodevelopment of animals (Sharp and Lunder, 2003). Low doses of
penta and octa PBDEs have been shown in lab animals to cause permanent learning and
memory impairment, thyroid hormone disruption, behavioral changes, hearing deficits,
delayed puberty onset, subtle changes in the structure of the ovaries, and decreased sperm
counts (Sharp and Lunder, 2003). Some of this research is showing effects in rats at
lower doses of PBDEs, as little as .8 milligrams per kilogram of body weight per day or
.8 ppm. These effective doses are lower than the levels of PBDEs found in some
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American women (Sharp and Lunder, 2003). Table 12 shows at the impacts of PBDEs on
lab animals after only a single dose.

Table 12: Overview of research done on PBDEs, where they are found, what animals they were tested, the
dose that was given to the animal and the toxic effect of this dose (Sharp and Lunder, 2003).

PDBE congener

Part of what
commercial
mixture

Test
animal

PBDE dose
(mg/kg-day)
(ppm)

Toxic effect

Source

PBDE-209

Deca

Mice

2.2 (single
dose)

Caused aberrations in
spontaneous motor behavior and
habituation capability that
worsened with age

Viberg et al.
2003

0.8 (single
dose)

Effects on learning and memory,
spontaneous motor behavior and
habituation capability that
worsened with age

PBDE-99

Penta

Mice

Commercial
Penta Mixture
DE-71

Penta

Mice

0.8 (single
dose)

Significant decrease in thyroid
hormone (T4) levels

PBDE-99

Penta

Rats

0.06 (single
dose)

Decreased sperm count

PBDE-99

Penta

Rats

0.06 (single
dose)

Changes in subcellular structure
of ovaries

Eriksson et al,
2002
Eriksson et al,
2001
Fowles et al,
1994
Kuriyama and
Chahoud,
2003
Talsness et al,
2003

One study exposed rat newborns to deca at a critical stage of brain development and
found that these rats had “irreversible changes in adult brain function” which worsened
with time. These rats were tested as adults and found to have “neurobehavioral
derangements” (EU, 2003)(Viberg et al., 2003). Two other separate studies found similar
neurobehavioral impacts to newborn rats and mice exposed to low doses of tetra and
penta-BDEs (Eriksson et al., 2002)(Eriksson et al., 2001b)(Branchi et al., 2002). Similar
to DES exposure, rats that were exposed to deca at a different stage in their development
showed no adverse effects.
Most of these impacts are connected to PBDEs’ impact on thyroid function within
the body which is also a targeted hormone of PCBs. Multiple studies have shown that
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short term exposures to mixtures of PBDEs or individual cogeners can alter animal
thyroid levels (Sharp and Lunder, 2003). Altered thyroid levels can result in depression,
fatigue, unexplained weight gain, low libido in adults, hair loss and more severe impacts
on developing fetuses and infants (Porterfield, 1994). Hypothyroidism in pregnant
women can result in fetal abnormalities and also impaired cognitive abilities of their
offspring. Research revealed that women in their first trimester with levels of thyroid in
the lowest 10% of the population were more likely to have a child with a IQ of less than
85, which is the 20th percentile of IQ scores. They were also five times more likely to
have children with a low enough IQ to be categorized as mildly retarded (Pop et al.,
1999). The long term impact of exposure to these thyroid disrupting chemicals is largely
unknown, but important because long term studies of other thyroid disrupting chemicals
at low levels have shown to cause serious harm (USEPA, 2002).
PBDEs are closely related to PCBs, which have been banned in the 1970’s due to
their toxicity, but still persist in the environment now. Like PCB’s, PBDEs are very
persistent and bioaccumulative. Many PBDE’s are toxic alone, but also can breakdown in
the environment into more toxic PBDEs. They have found PDBEs polluting every area of
the world where scientists have looked. These chemicals have been found in the tissues
of whales, birds, and bird eggs seals, moose, reindeer, mussels, eels and fish; in human
breast milk, hair, fat and blood; in twenty different countries and remote areas such as the
North Sea, the Baltic Sea and the Artic Ocean (Sharp and Lunder, 2001).
A study done by the EWG on mothers and their female offspring showed that
consistently more PBDE was found in the mother than in the daughter. Women pass
much of their body burdens to their offspring of fat soluble pollutants such as PBDEs
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during pregnancy. Figure 7 is a diagram showing that it takes 12 years for a child to
excrete 99% of the penta-bde that she has inherited from her mother.

Figure 7: The estimated time it takes daughters to excrete the pollutants that they inherit from their mothers
(EWG, 2003a).

It is also plausible that because this pollutant bioaccumulates, women who have lived
longer and been exposed to more PBDEs could have higher concentrations (EWG,
2003a). Compared to the other pollutants such as lead, penta takes less time to be
excreted but while daughters are excreting their mother’s pollutants, other pollutants they
are exposed to daily in their lives are adding to their body burdens.
A Swedish study in 1999 reported that between 1972 and 1997 PBDE levels in
women’s breast milk have increased 60 fold (Meironyt and Bergman, 1999). Levels in
Americans is far greater in than any other people of the world. The EWG tested the milk
of 20 first time mothers and found the median level of PBDE’s to be thirty times greater
than recent European studies (2003). Another EWG study looked at a sample of Texas
woman and found that twenty percent of them had 12 ppb of PBDE-99 in their breast
milk (Sharp and Lunder, 2003). One study conducted in 2003 reported that 13.5% or
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more of Deca remained in the liver, brain and hearts of mice 24 hours after they received
a dose of the chemical (Viberg et al.)
Deca usually is present in lower concentrations in wildlife and humans than other
PBDEs. However, some studies have shown deca to be 25% of the total PBDE body
burden of some people (Sharp and Lunder, 2003). In the same EWG breast milk report,
deca was found in American mother’s breast milk in concentrations as high as 1 ppb,
while 8 Texan women had levels as high as 8 ppb of deca detected in their blood (EWG,
2003b) (Schecter et al., 2003). Figure 8 compares the levels of PBDE’s found in the
Texas study, European studies and the EWG’s breast milk study. The EWG report

PBDEs (ppb) detected in breast milk

mentioned earlier confirms that mothers are indeed passing these chemicals onto their

Particular study that looked at PBDE levels

Figure 8: Comparison of levels of PBDEs in breast milk found in four separate studies (EWG, 2003b).

children either through breast milk or in utero (EWG, 2003b). Not only does this research
provide evidence that PBDE is contaminating adults, but it is also worrisome because it is
being passed down to infants through breast feeding during sensitive development stages.
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The EWG took their breast milk study a step further and examined the levels of
PBDE’s in the dust of the homes of the breast milk study participants they had analyzed
earlier. Chemicals that are inhaled can be absorbed in the lungs, enter the blood stream
and then can circulate to other parts of the body. The dust in these women’s homes had
extremely high levels of PBDE’s. Half of the homes had levels that exceeded 3,000 ppb
and a median level of 4,629 ppb. All of the homes had levels ranging from 614 to 16,366
ppb. These levels were comparable to studies done on the dust in European homes. A
study done on house dust in Cape Cod, MA was the only other study done of this nature
and reported and average PBDE concentration of 369 ppb and a maximum of 11,426 ppb
(Rudel et al., 2003). Deca comprised 42% of the PBDE that was found in the dust (Sharp
and Lunder, 2003). Dust is of particular concern for small children who spend much of
their time on the ground and putting things in their mouths, which could be contaminated
with PDBE dust.
As mentioned earlier, many of the health impacts associated with PBDEs result
from exposures below what many are exposed to. Studies have shown that humans are
being exposed to levels of PBDEs that have been shown to be harmful in animal studies.
As mentioned earlier, 20% of Texas women had concentrations of 12 ppb of in their
breast milk and concentrations of 4-12ppb in the brain of rodents have been shown to be
harmful in animal studies (Sharp and Lunder, 2003). However, there is limited
information on the impact of brain tissue contamination versus breast milk
contamination, so it is difficult to say that human exposures are greater than the levels
known to have severe impacts on rodents brains (Sharp and Lunder, 2003).
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Some research suggests that Deca can degrade into PBDFs (polybrominated
dibenzofurans), a dioxin like chemical, when exposed to ambient sunlight (Selstrom,
1998)(Olsman, 2002)(Eriksson, 2001a). Low levels of chemicals very similar to these
have been shown to cause cancer and birth defects (Sharp and Lunder, 2003). The EPA
announced in 2003 that Deca can be changed “to form more toxicologically active lower
brominated forms” (USEPA, 2003). These forms with 5 or 4 bromines have been shown
to be more toxic and bioaccumulative than deca. However, further research is needed on
the toxicity of these other forms that originate from Deca. Linda Birnbaum from the
Environmental Protection agency said that:
There is now good evidence that Deca can and does break
down both in the environment and in fish, as well as in
rats…. We really don’t know if the breakdown products are
contributing to the body burdens of these congeners in
biota and people. We also don’t know the toxicity of these
specific cogeners, although at least one of them…has been
known to be developmentally neurotoxic by studies in
Sweden (Sharp and Lunder, 2003)
Deca is not only breaking down in the environment but studies suggest that deca breaks
down into less-brominated forms while stored in organisms (Sharp and Lunder, 2003).
For all of these endocrine disrupting chemicals, there is limited research on the additive
effects of these chemicals on the body. This is of particular concern with PBDEs because
most people have multiple forms of these chemicals stored in their bodies. A few studies
have examined the combined impacts of PBDEs and other chemicals such as PCBs, and
found that in combination they are more harmful than individually. (McDonald, 2003)
(Eriksson, 2002).
The US EPA’s Voluntary Children’s Chemical Evaluation Program (VCCEP)
looked at levels of a range of different chemicals in American children. It found that
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children are being exposed to levels of deca that are at least 1 order of magnitude below
what the National Academy of Science references as a safe dose of 4mg/kg/day of 4 ppm,
which suggests that deca exposure could be a risk to children (Hayes and Pyatt, 2006)
On July 1, 2007 the EU will ban the sale of all new computers, televisions and
other electronic products that contain the deca-BDE. This is coming after a bill enacted
by the EU outlawing other brominated flame retardants that are known to be toxic
(Washington Toxics Coalition, 2006). Many of these chemicals are of importance
because they are readily found in the breast milk of European women (Enviro. Health
News, 2007). This decision also initiated the outlawing of deca in electronic equipment
whenever in addition, a certain amount of a component of penta is found on the electronic
products (Valeriano, 2006). In 2003, following the research of the buildup of PBDEs
California followed Europe and led the US by banning the penta and octa forms of the
chemicals by 2008. Hawaii, Illinois, Maine, Maryland, Michigan, New York,
Washington and Oregon also have banned penta and octa from use in their states. Due to
this law, the EPA has worked to stop production of penta and octa by 2005 and they have
received an agreement by industry to phase-out production by the end of 2004. As a
result American companies such as Dell, Panasonic, Apple, Dell, Hewlett-Packard, and
Sony have eliminated PDBEs from their products. Ford has also eliminated PBDEs from
the contents of the car that drivers come in contact with (Gearhart and Posselt, 2006).
Some chemical companies have also voluntarily agreed to start testing some of these
widely used chemicals for toxicity (Sharp and Lunder, 2003). The international
Stockholm Convention of 2003, which identifies and attempts to regulate persistent
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organic pollutants, is considering penta-BDE as a viable persistent organic pollutant due
to its toxicity and persistence.
Despite the fact that penta is being phased out, though soon to be limited, deca
still remains on the market because of the controversy over its toxicity. A risk assessment
conducted by the European Union in 2004, which looked at over 588 studies concerning
deca toxicity, found that deca-BDE does not post a significant threat to human health or
the environment (BSEF, 2005). The government did not entirely outlaw the use of the
chemical but the companies producing it have agreed to reduce emissions into the
environment over the next 6-10 years. A Japanese report confirmed the EU findings in a
similar risk assessment.
Critics claim government regulation is insufficient due to the mounting
information that shows deca degrades into more harmful forms of PBDEs. This
transformation and the potential additive impacts of these chemicals were not included in
the risk assessment conducted by the European Union. Soon after the EU report was
released Sweden announced that it intends on eliminating deca from their country. The
Danish government also announced that they will be taking legal action again the EU’s
negligent deca decision (Gearhart and Posselt, 2006). Alternatives for these flame
retardants do exist, but some of them such as tetrabromobisphenol-a (as mentioned
earlier) and HBCD (hexabromocylodondecane) which is thought to be toxic also. The
least harmful alternatives are those that do not contain chlorine or bromine (Sharp and
Lunder, 2003).
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Perflourinated Chemicals (PFCs)
PFCs or perfluorinated chemicals are another class of potentially serious
endocrine disruptors. They are also some of the “miracle” products of the half century,
Teflon™, Scotchguard™, Gore-tex™ and Stainmaster™. These chemicals resist
substances absorbing or sticking to the materials they are applied to. These products are
also used in everything from computers to airplanes to cosmetics and household cleaners
because of their repellant properties. It is a 5 billion dollar industry dominated by large
chemical companies such as DuPont and 3M. (EWG, 2006). There are many different
types of PFC substances. Table 12 shows a breakdown of forms of PFCs.

Table 12: Summary of commonly used PFCs.
Type of PFC
Perfluorooctanoic acid (PFOA)
Perfluorooctane sulfonate
(PFOS)
Perfluorohexanesulfonate
(PFHS)
Perfluorooctanesulfonamide
(PFOSA)

Uses/Products
Industrial surfacant, key ingredient in Teflon
(DuPont)
Industrial surfacant, key ingredient in Scotchguard
(3M) before reformulation in 2000, fire-fighting
foams, anti-reflective coating
Firefighting foams, carpet treatments

Other Names
C8

*Degradation product of PFOS

N/A

perfluorooctanyl
sulfonate
N/A

As with many of the products the information on the health impacts of PFCs is constantly
emerging. Table 13 below is an overview of the certainty of the information that is
available for the different health impacts potentially associated with PFC exposure.
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Table 13: A summary of the amount of available health information available on PFCs (EWG, 2007b).
Top health concerns for PFCs
Health Concern or Target Organ
Cancer
Birth defects and developmental delays
Endocrine system
Other health concerns for PFCs
Biochemical effects
Persistent, accumulates in wildlife and or/people
Reproduction and Fertility
Hormone Activity
Kidney and renal system
Brain and nervous system
Immune system (including sensitization and allergies)
Behavioral effects
Hematologic system

Weight of Evidence
limited
limited
limited
known
probable
known
known
known
known
known
known
known

Two of the three top health concerns categorized for PFCs were birth defects and
developmental delays and the impacts on the endocrine system. Due to the lack of
information available however, both bodies of knowledge supporting these impacts are
“limited”. Some reproductive and fertility impacts and hormonal impacts of PFCs are
“known” but are not considered by this project to be the most serious health problems.
PFOS are shown to be toxic to mammalian species. The toxicity of PFOS is
similar among rats and monkeys. Repeated exposure is toxic to the liver and caused death
and mortality, the dose-response curve has an exponential form. This occurs in animals of
all ages, although infants and newborns may be more sensitive. Epidemiologic studies
have linked PFOS exposure with incidence of bladder cancer in humans, however further
work is needed to clarify this relationship (OECD, 2007) Specifically research is needed
to understand how the human body metabolizes PFOS.
In 2003, the EPA conducted a risk assessment for PFOA, the main chemical in
Teflon. This report also noted a significant decrease in organ weight when animals were
exposed to PFOAs, which is a sign of toxicity and organ damage (EPA, 2003, Risk
Assessment,). In the most recent report, PFOA was classified as “a likely carcinogen in
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humans” (EPA, 2003). In addition, a 2-year study of rats has shown that exposure to
PFOS results in liver and thyroid cancer. PFOA exposures caused liver, pancreatic,
testicular and breast tumors in rats (EPA, 2002). A study done in the Journal of
Occupational Medicine focused on workers at a Dupont factory that were constantly
exposed to these chemicals. They looked at 2,788 males employed between 1947 and
1983 at a Minnesota plant. Working for ten years and being exposed to PFOA produced a
3.3-fold increase in prostate cancer deaths compared to those with males with no
exposure. Both DuPont and 3M claimed that the small sample size invalidated the results
(Gilliland and Mandel, 1993)
PFOA has also shown to disrupt the thyroid, which as mentioned earlier, can have
significant impacts. Industry studies have shown increased levels of thyroid stimulating
hormone, which generally results from an underactive thyroid, in plant workers dealing
with high PFOA levels in their blood (Dupont, 1997)(Olsen et al., 1998). Between 1978
and 2002, scientists have documented thyroid damage in eleven separate reports caused
by PFOA. There was a decrease in the growth of the pituitary gland of offspring whose
mothers were exposed to 120ppb of PFOA (EPA, 2003). Five studies also showed that
PFOA exposure altered the endocrine system in males by increasing their levels of
estrogen and caused abnormal testosterone regulation (EWG, 2006).
A study by Yang et al. determined that PFOA caused immunosuppression
(2002b). Scientists have not been able to find a dose of PFOAs that does not impact a
component of the immune system in which there are four organs and at least nine
different types of cells (Yang et al., 2002b, 2000a, 2000, 2001). In an industry study
conducted in 2003, every dose that was examined negatively impacted the spleen which
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is responsible for producing anti-bodies necessary for proper immune function (38). A
Swedish study also found that PFOA lowered the number of every immune cell they were
studying, 8 in total, in the spleen and thymus. There was also an increase in white blood
cells in the blood of PFOA workers, a biological response to infection (Dupont, 1997).
Impacts on the immune system in children are especially detrimental because they can be
permanent. Early exposure to PFOAs could damage immune cell function, which could
increase the risk of infection and disease, including cancer later in life (EWG, 2006)
PFOA has also been shown to cause reproductive problems and birth defects.
When PFOA exposed female rats gave birth to pups, there were a greater number of
fatalities in their litters during infancy (EPA, 2003). Exposures that impacted the fetuses
had little or no effect on the mother rodents. A study reviewed the assessment, which
looked at higher concentrations, 1 part per million of PFOA exposure to mothers; 6 of 70
female pups died and 6 of 70 male pups died while they were infants (York, 2002).
Another 3M study showed that PFOA was more toxic to rabbits in utero, but did not
impact the mother. In 1981, DuPont also found PFOA in the umbilical cord blood of
children whose mothers were workers at a PFOA plant. Two out of seven pregnant
workers gave birth to babies with eye, tear duct and nostril defects; soon after DuPont
reassigned 50 women from that plant (EWG, 2006)
Many of these PFCs break down into their metabolites (PFOAs) which
accumulate in the environment and in the human body. Multiple species of wildlife have
shown to be contaminated with PFOA and Table 14 shows a breakdown of the
percentage of the different species that were found to be contaminated with PFCs.
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Table 14: The contamination of wildlife with PFOA (EWG, 2003)
Species
Marine Mammals
Mink and otter
Birds
Fish

Maximum concentration ng/g/wwt
1520
4900
2570
1000

Frequency of detection
77%
100%
60%
38%

Different animals species are able to metabolize PFOS at different rates. The half-life
PFOS in rats is 100 days, in monkey 200 days and years in humans. In the EPA risk
assessment on PFOA it was concluded that in female rats PFOA has a half-life of 1.9-24
hours while in male mice the chemicals had a half-life of 4.4 to 9 days. It is postulated
that hormones dictate the difference.
PFCs contaminates wildlife, but it is also found in the air, water and food.
Research down by the organization Health Canada and Environment Canada concluded
that PFCs bioaccumulate up the food chain, much like PCBs do (Martin et al., 2003). 3M
conducted a study on 6 cites, 3 of which used PFCs heavily (where manufactured or
supply chain cities). All 6 cities had PFC water contamination and 5% of groceries that
were tested had traces of PFOA. The beef, green beans, apples and bread that were tested
all contained PFOA (3M, 2001). Table 15, adapted from an Environmental Working
Group Study exhibits PFC bioaccumulation ability and the presence of some of these
chemicals in foods. The bioconcentration factor is defined by the EPA as a ratio used to
describe the accumulation of chemicals in living organisms that live in contaminated
environments.
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Table 15: Description of the multiple forms of PFCs, their sources, their bioaccumulation factor and how
they are known to contaminate the food supply (EWG, 2006).
Chemical

Source

PFOA (Teflon,
Stainmaster)

Pollution from Teflon™ plants,
offgas from Teflon™, breakdown
product of Stainmaster™ and
other PFC products

PFDA (10-carbon
version of PFOA)

Breakdown product of
Stainmaster™ and other PFC
products
Breakdown product of 3M’s old
Scotchguard™ formulation (pre2000), used in packaging
materials
Banned chemicals formerly used
in electrical capacitors and other
industrial applications
Breakdown product of
Stainmaster™ and other PFC
products
Breakdown product of
Stainmaster™ and other PFC
products
Breakdown product of
Stainmaster™ and other PFC
products

PFOS
(Scotchguard)
PCBs (Aroclor
1242)
PFUnA (11carbon version of
PFOA)
PFDoA (12carbon version of
PFOA)
PFTA (14-carbon
version of PFOA)

Bioconcentration factor
(potential to contaminate the
food chain and concentrate in
humans)
4.0 ± 6.0

Known food supply
contamination
Found in produce, meat,
and bread in grocery
stores
No tests available

450 ± 62

1,100 ± 150

1,000 to 25,900

Multiple foods that are
packaged in PFOS
Widely contaminates
meat and dairy products
around the world
No tests available

2,700 ± 400
No tests available
18,000 ± 2700
No tests available
23,000 ± 5300

Many chemicals, especially those that are hydrophobic can be stored in the fatty tissue of
an organism and bioaccumulate. If the compounds cannot be metabolized as quickly as
they are consumed, which is certainly the case for PFCs, the magnification of potential
toxicological effects up the food chain can be severe.
One exposure pathway occurs when Teflon™ releases PFOA though the
manufacturing process. One study showed that it is also released in addition to other
PFCs, when Teflon cookware is heated to high temperatures (Ellis et al., 2000). PFCs
from other products like Gore-tex™ and Stainmaster™ carpet could be present in our
bodies due the high amount of these chemicals in the environment.
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PFCs have been compared to chemicals like DDT and dioxin; the most toxic and
persistent PFCs have not been found to degrade in the environment (EWG, 2006).
Human body burden data in table 16 shows that PFCs were found in blood of 18 different
blood banks in the United States and blood samples of people of rural China. Only one
sample ever tested for PFCs did not have detectable levels of the chemicals. This is
because the sample was taken between 1948 and 1951, ten years before PFCs were
commonly used in consumer products.

Table 16: Past studies done on blood, urine and fat samples examined for PFC concentrations (EWG,
2006).
Year
1957
1969-1971

Place
Sweden
Michigan

1971
1976

Sweden
U.S

1980

U.S

1984

Linxian rural China
province
U.S

1985
1994

1999

Shandong, rural China
province
US, 23 states and District
of Columbia
Seattle ,WA

2000-2002

U.S.

1995

Sample type
10 individual samples
5 individual samples from
a breast cancer study
10 individual samples
6 pooled samples from
heart disease study
6 pooled samples from
heart disease study
6 individual samples

Type of PFC Detected
PFOS
PFOS

3 individual samples from
heart disease study
6 individual samples

PFOS

598 children sample

PFOS, PFOA, PFHS, PFOSA,
PFOSAA, M570, M556
PFOS, PFOA, PFHS, PFOSA,
PFOSAA, M570, M556
PFOS, PFOA, PFOSA, PFOSAA,
M570, M556, C6, C7, C9, C10,
C11,C12, THPFOS, THPFDS

Elderly
600 samples from
commercial and blood
banks sources

PFOS
PFOS
PFOS
PFOS

PFOS

These studies confirm that PFCs are present in the general population (EWG, 2006).
A study conducted by 3M found that 96% of 598 children who lived in 23 states
and the District of Columbia found detectable levels of PFOA in their blood (Olsen,
2000). Throughout the research all of the PFCs that have been tested for have been found
in human blood. Eight of these chemicals stem from the original Scotchguard™ (3M)
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formulation while the other seven are thought to originate from Teflon™ (DuPont)
products. PFHS was found in 61 of the 64 people tested in one Environmental

Working group study and in all of the 1,591 tested in CDC biomonitoring studies
(EWG, 2006) (CDC, 2005).
Another industry study found that children had a higher concentration of the
majority of PFCs detected in blood than the adults tested. Some had levels equal to
workers in 3M factories, at a maximum concentration of 515 ppb (3M, 2001). A 1999
study of elderly people in the US revealed body burdens of 100 ppb of PFHS while a 3M
study 2 years later in 2001 found PFHS at seven times this concentration in children. One
certain type of PFC, M556, was only found in 5% of the adults tested, but was in all of
the 598 children that were tested in 1995. M556 is a breakdown product of Teflon™,
which suggests that children are being exposed to more Teflon than adults or that
children are metabolizing these chemicals different that adults. In contrast however a
Norwegian study also showed that body burdens of brominated flame retardants have
increased since the 1970’s and children age 0-4 had elevated exposures (Thomsen, 2001).
The EWG report suggests it takes the body an estimated 4.4 years to excrete 50% of the
PFOA that is accumulated in the organs and tissues (EWG, 2006). However, constant
PFOA exposure does not allow the body to ever eliminate PFOAs completely.
PFOs were the primary chemicals used in Scotchguard™, a stain and water
repellant made by 3M. After the mounting evidence of this chemical’s toxicity, 3M
reformulated Scotchguard ™ and 3M also stopped manufacturing PFOA (EWG, 2006).
Unfortunately, because no evidence demonstrates that PFOA breaks down in the
environment, even if it were banned, its persistence could make it a continuous threat to
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the human population and environment. Some evidence suggests that other PFCs do
break down, but their decomposition stops when they become PFOA, PFOS and other
products that do not further degrade. Even if all PFCs were banned there would be
continual rise in PFOA exposure as all the remaining PFCs degrad until they reach the
terminal PFOA state. (EWG, 2006).
Not only are consumers being exposed through these common products, but
companies such as 3M have released tons of PFCs, PFOAs, and PFOs into the water, air
or landfills. These chemical companies are not legally obligated to report release of any
of these chemicals (EWG, 2006). No universal law bans the use of PFCs in the United
States. Limits are set for the amount of the chemicals that are in drinking water, but many
times these levels aren’t monitored and as mentioned earlier much is unknown about how
low “safe” concentrations affect the body. However, individual states are beginning to
craft legislation regarding these chemicals. Minnesota for example in April of 2007,
voted to establish maximum concentrations or health-risk limits for 3M chemicals PFOA
and PFOS by August 1. This action was in response to PFOA and PFOS were found in
local bluegill fish (Braun, 2007).
Parabens
Parabens are commonly used as preservatives in food, pharmaceuticals and
cosmetics. They are also antibacterial agents in some toothpastes. This chemical is used
heavily because of its inertness, wide range of uses, legislative acceptance worldwide,
low cost and biodegradability. It was thought to be safe and has been used since 1920.
(Routledge et al., 1998). Parabens are so pervasive that it is difficult to find certain
products, such as body lotions and after shaves, that do not contain them. A review in
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2004, examining 17,907 products, found that 82% contained either -methyl, - propyl,
and/or ethylparaben (Steinberg, 2004). Its main routes of human exposure are ingestion
and absorption through the skin.
The four commonly used parabens are methylparaben, ethylparaben,
benzylparaben, propylparaben, and butylparaben (see Figure 9).

Figure 9: Different paraben structures (Darbre et al., 2003).

Many products contain two or more types of parabens. The longer the molecular carbon
chain of a paraben the higher the degree of estrogenic activity.
Parabens have been reported to be weakly estrogenic but data are limited on the
long term effects of low paraben exposures. Soni et al. reported on the estrogenic activity
of the different parabens as compared to estradiol (Table 17). Butyl paraben has
repeatedly been shown to be the most estrogenic paraben, but compared to estradiol all
the parabens are many magnitudes less estrogenic.
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Table 17: Comparison of estrogenic activity of 3 different parabens to 17ß-estradiol (Oishi, 2002)
Paraben
Ethylparaben
Propylparaben
Butylparaben

Potency compared to 17ß-estradiol
150,000 less potent
30,000 less potent
10,000 less potent

Despite the mild estrogenic activity of these chemicals it has been found that they
are detrimental to the reproductive system in vitro. Propyl parabens added to rodent diets
resulted in a statistically significant reduction in sperm count and a reduction in the
concentration of testosterone in the semen. Adequate sperm count is imperative for
reproduction and testosterone is essential for male reproductive development and sperm
production. The level at which this disruption occurred is at the upper threshold of the
acceptable daily intake of parabens for people (10mg/kg body weight/day or 10 ppm)
determined by Europe and Japan (Oishi, 2002). In this same study however no decrease
in reproductive organ weight was found after paraben exposure. Inhibition of growth of
the reproductive organs is an indictor of estrogenic effects and has been used to
determine estrogenic potency (Heywood and Wasdsworth, 1980; Hart, 1990). Darbre et
al. (2003) examined the estrogenic effect of benzylparaben and found that it did exert a
mild estrogenic effect and bound to estrogen receptors in mice.
The most compelling research on parabens has been its recent link to breast
cancer. Breast cancer is one of the leading causes for premature death in American
women. One of the risk factors attributable to this disease is a woman’s exposure to
estrogens. Darbre (2003) examined samples from twenty breast tumor cells from different
women and found parabens present in all the samples. This is of concern because the
cause of breast cancer is relatively unknown and there is increased incidence of tumors
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forming in the upper outer part of the breast where deodorant, almost all of which contain
parabens, are applied daily. Dabre (2003b) hypothesizes that the introduced chemicals
could bind to DNA and promote the growth of damaged cells, eventually resulting in the
cancer.
A review conducted by Golden et al. (2005) on the endocrine activity of parabens
found that when compared to DES and estradiol “it is biologically implausible that
parabens could increase the risk of any estrogen-mediated endpoint, including effects on
the male reproductive tract or breast cancer.” This review examined both the dose and
potency of parabens was examined to determine if they were detrimental.
Parabens are quickly absorbed, metabolized and excreted from the body. A
difficulty with determining the potential effects of parabens is the unknown degree of
exposure. Despite the variance in absorption of the products, low penetration rates at a
consistent rate over a large area of the body in most cases, could result in considerable
amounts entering the body (Dal Pozzo and Pastori, 1996). Traces of unmetabolized
parabens have been detected in urine, which suggests that detectable levels of
unmetabolized parabens could be circulating in the body for an extended amount of time
(Routledge et al., 1998). It is estimated that each person consumes 1.3 mg/kg or 1.3 ppm
per day (Soni et al., 2001). Like the other chemicals mentioned, toxicity data based on
large doses of parabens is less important when the majority of the population is exposed
to small consistent amounts of these chemicals. Routledge et al. (1998) claim that it is
important to understand the impacts of small doses of parabens over a long period of
time, because many are subject to these exposures.
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No current regulation governs against parabens use in products. Many claim that
further research is needed to conclude that parabens are harmful. Due to public pressure
many companies are now manufacturing paraben-free personal care products.

Compiled Chemical Information
Table 18 is a synthesis of the information compiled on the chemicals I focused on.
It is refined to examine the specifics about these chemicals that are pertinent to the Colby
community and to my scoring system. It examines the products that contain these
chemicals, the health impacts of exposure to these chemicals, the extent of the exposure
to these chemicals and the potential body burdens of Colby students.
Table 18: Synthesis of information accrued from literature review.
Chemical

Products

Route of Exposure

Health Effects

BPA

Polycarbonate water bottles
(Nalgene™ bottles), lining
of food and beverage cans,
flame retardant

Ingestion of contaminated
food and beverages,
inhalation and skin
absorption

Phthalates

Personal care products,
plastics

PBDEs

Furniture, fabric, electronic
equipment

Skin absorption, ingestion
of contaminated food or
beverages, inhalation of
vaporized particles
Skin absorption, ingestion
of contaminated food or
beverages

PFCs

Teflon treated pans,
Scothguard ™ treated
fabrics, Gore-tex ™ treated
clothing, Stainmaster ™
carpet
Personal care products

Birth defects,
impaired
reproductive
capacity, immune
function, cancer cell
predisposition
“phthalate
syndrome,” impact
reproductive
capacity (males)
impact on thyroid
function, birth
defects,
developmental
impacts, connected
to cancer
Likely carcinogen,
immunosuppression,
birth defects,

Parabens

Ingestion of contaminated
foods, inhalation, skin
absorption
Ingestion of contaminated
foods, skin absorption
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Reproductive
capacity, found in
breast cancer cells,

Body
Burden
Found in
majority of
population but
not persistent
Found in
majority of
population and
not persistent
Found in
majority of
population and
highly
persistent
Found in
majority of
population and
persistent
Limited
information on
body burdens,
small
consistent
exposure

Heath Impact Scores
The scores given here for each chemical are based on the results of my literature review,
in which I characterized the potential for each chemical to act as endocrine disruptors.
Score: Bisphenol-A
Category
Scale
Severity of Health Impacts
Persistent Exposure
Uncertainty
Overall Score

Score
3
3
2
3
2.75

Scale: 3
Bisphenol-a is high volume chemical found in products worldwide. Exposure to this
chemical, and everyone is potentially impacted by BPA at high and low doses. It is
known to leach from polycarbonate plastic and into the foods stored in cans lined with
BPA resin. Urine samples and body burden research has shown that bisphenol-a is
commonly detected.
Severity of Health Impacts: 3
Multiple studies have shown the severe impacts of BPA on developing fetuses. These
impacts occur in utero and can have lasting impacts on the health of the exposed. The
health impacts can range from low sperm count, to enlarged prostate glands, to oocyte
chromosome damage, to growth of mammary gland cells and early maturation of
females. Breast and prostate cancer have been linked to fetal exposure to BPA and in
vitro chronic adult exposure has caused insulin resistance. Exposure can impact future
fertility and many other body functions.
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Persistent of Exposure: 2
BPA does not bioaccumulate in the environment. BPA does not accumulate in the fatty
tissues and in turn the amount of BPA does not increase over a lifetime. Regardless, due
to pervasiveness in the environment and the levels that leach from these products, there is
chronic daily exposure to BPA.
Uncertainty: 3
There is no argument against BPA being an endocrine disrupting chemical. The health
impacts of low doses have been criticized, but the majority of research that has shown
that BPA does not have an impact at low levels have been funded by interest
organizations such as the American Plastics Council (vom Saal, 2005). A significant
uncertainty within the research is that it is all based on animal studies, which is typical of
toxicology research. Despite this over 150 studies have shown negative impacts of this
chemical on multiple aspects of health.
Score: Phthalates
Category
Scale
Severity of Health Impacts
Persistent Exposure
Uncertainty
Overall Score

Score
3
3
2
2
2.5

Scale: 3
According to the EWG report phthalates are found in the vast majority of mainstream
personal care products that were tested. The majority of the population uses some form of
these products while children and woman of childbearing age are known to been exposed
to higher levels than the average person.
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Severity of Health Impacts: 3
Phthalates impact the male reproductive system resulting in lowered testosterone,
reduced sperm count and motility, male reproductive tract defects and increased
reproductive cancers. “Phthalate syndrome” is a term coined by the EPA to define the
multiple reproductive impacts that result from phthalate exposure.

Persistent Exposure: 2
Phthalates do not bioaccumulate in the environment. Phthalates do not accumulate in
fatty tissues and in turn the amount of phthalates does not increase over a person’s
lifetime. Regardless, due to pervasive use in products and the low levels that leach from
these products, there is daily chronic exposure to phthalates.

Uncertainty: 2
Ample animal data demonstrates the impacts on the reproduction of low phthalate
exposure. One type of phthalate has been categorized as “serious concern” for human
health. Toxicity research available on other phthalates has not convinced policy makers
that they are a serious threat to endocrine health.
Score: PBDEs
Category
Scale
Severity of Health Impacts
Persistent Exposure
Uncertainty
Overall Score
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Score
3
2
3
1
2.25

Scale: 3
PBDEs are found in many products that are widely used by Americans. The majority of
the population uses some form of these products while children between the ages of 0-4
have been found to have higher concentrations.

Severity of Health Impacts: 2
PBDEs are known to impact thyroid function, which controls brain development,
metabolism and growth and have been tied to some cancers. Birth defects have resulted
from PBDE exposure.

Persistent Exposure: 3
Forms of PBDEs have been found everywhere in the world, including the Arctic, they are
thought to be highly persistent and remain in the environment for a long time. They are
excreted from our bodies but the levels are constantly replenished through daily
exposure. The major route of PBDE exposure is through food contamination.

Uncertainty: 1
Limited information is known on just how these chemicals work in the body. Much of the
regulation that has been done on PBDEs has been based on looking at past health
information of similar chemicals. We have limited data in humans for many of the
PBDEs. Preliminary evidence suggests they act as PCBs in the body, which are well
known hazardous chemicals.
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Score: PFCs
Category
Scale
Severity of Health Impacts
Persistent Exposure
Uncertainty
Overall Score

Score
2
3
3
1
2.25

Scale: 2
Many are exposed to these chemicals, especially Americans, while some people have
higher concentrations than others. People may or may not use products containing PFCs,
so the use is possibly less ubiquitous. PFC chemical workers and people who live near
the plants manufacturing these chemicals have increased exposure.

Severity of Health Impacts: 3
Research available has connected PFCs to birth defects, cancer and immunosuppression.
It has also been shown in industry research to disrupt the thyroid potentially resulting in
developmental impacts on developing fetuses and thyroid cancer.

Persistent Exposure: 3
PFCs persist in the body for up to 60 years after exposure and is highly persistent in the
environment. In addition to their pervasiveness in the body, there are consistent low
levels that leach from certain products which causes low-level chronic PFCs exposure.

Uncertainty: 1
Limited information is available on the impacts of PFCs on humans. Much of this
research is still emerging and is coming from occupationally exposed people. The

76

available information is mainly provided by industry scientists, which historically can be
less reliable than independently funded research.

Score: Parabens
Category
Scale
Severity of Health Impacts
Persistent Exposure
Uncertainty
Overall Score

Score
2
2
2
1
1.75

Scale: 2
Many people who use body products containing parabens are exposed to low levels of
these chemicals. Some products on the market exist without parabens, which lowers the
number of people who are exposed to them, but most of certain classes of products do
contain parabens.

Severity of Health Impacts: 2
Parabens have been shown to be mildly estrogenic, and scientists are unaware of any
significant impacts on people. However they have been shown in vitro to impact
testosterone production and lower sperm counts. They have also been found in breast
cancer cells, though no study has been shown to link parabens to breast cancer. A broad
understanding of endocrine disruption, however, suggests the potential that harmful
effects may be uncovered with further research.
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Persistent Exposure: 2
Parabens do not persist in the environment or the body. They are readily excreted from
the system and break down in the environment. However, people who constantly use
personal products with paraben are receiving a consistent daily dose of the chemicals,
which maintains a constant mild Persistent Exposure of these chemicals in the body.

Uncertainty: 1
There are limited data on the toxicity of parabens in general. The majority of the data
supports parabens’ less widespread impacts on health. Due to the lack of information on
parabens it is difficult to get a sense of the toxicity of the chemical.
Parabens are a useful example to use in my scoring system. We know they are
mildly estrogenic, but we don’t have much information to show how they impact the
endocrine system, and limited data suggest less widespread effects. That it gets a lower
score shows the responsiveness of my scale to chemicals that are less studied and are
postulated to be less harmful to the endocrine system.
Cumulative Table
Chemical
Cumulative Score
Bisphenol-a
2.75
Phthalates
2.5
PBDEs
2.25
PFCs
2.25
Parabens
1.75
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DISCUSSION
Score Rationale
There are multiple different ways to account for the impacts of something on
human health. To develop my score, I mainly examined past assessment methods and
applied my own assumptions. I looked at the four areas, scale, severity, persistent
exposure and uncertainty, because they are commonly used in classic toxicological health
assessment. I scored each individual area based on the information I collected in my
literature review. I weighed each area equally, when calculating the overall score,
because I truly found no compelling reason not to do so. Uncertainty, in particular, is
weighted equally to the other categories because endocrine disruption is an emerging
field of research.
Chemicals and Products of Concern
This score is only one part of a comprehensive review of a product’s impact on
health. I did not attempt to give a full list of products or quantify how much of a chemical
are in products, exactly how often Colby students are exposed and if there are
demographic age differences concerned with exposure. My score attempts to measure the
degree to which the major chemical components of key products impacts endocrine
health. It may be most useful for Colby to use to set priorities for purchasing decisions.
For the chosen chemicals, my score is based on the direct health impacts of the
use of certain products with these chemicals. I did not consider global or indirect health
effects resulting from the entire lifecycle of the chemicals and products. Bisphenol-a and
phthalates are the chemicals that scored the highest on my scale, 2.75 and 2.5
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respectively, with a 1 being of least concern and 3 being of most concern. Products
containing these chemicals should be of concern until further research dictates otherwise.
PBDEs and PFCs, with scores of 2.25 are of moderate concern mainly because of their
persistence in their environment and evidence for harm, though less comprehensive than
for BPA and phthalates. Parabens are of the least concern out of my five chemicals, 1.75.
This is mainly due to the lack of substantial data that links parabens to health problems.
Purchasing Alternatives
The impact of hazardous chemicals on our health can be reduced in many
different ways. The purchasing of green products, or environmentally preferable products
(EPPs), which contain recycled materials, minimize waste, conserve energy and/or water,
reduce the amount of toxic substances disposed of or consumed, or lessen the impact on
public health, are one way to reduce potential harm. Institutional and personal EPP
purchasing can limit contact with some of these substances that harm the endocrine
system. At this point, alternatives for some, but by no means most, of the products linked
to endocrine disruption exist.
Some alternatives for BPA are readily available for use. Consumers can use
tempered glass or polypropylene plastic instead of polycarbonate plastic to store foods
and liquids. Some types of polycarbonate are made from monomers other than BPA.
Aluminum, stainless steel or glass bottles can also be substituted for Nalgene™ bottles.
Avoidance of heating polycarbonate plastic is another way to limit exposure as more
BPA tends to leach out of heated plastic. Limiting consumption of canned foods,
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especially pasta and soup, and avoiding dental sealant are other easy ways to limit
exposure to BPA.
Companies who are required or voluntarily have phased out the chemicals are
actively using some alternatives to phthalates. To avoid using phthalates consumers in
US can choose to purchase personal care products from companies that have signed the
Compact for Global Production of Safe Health and Beauty Products to not use phthalates.
It is much more difficult and expensive to remove phthalate from construction materials
because they are added to PVC plastics. Consumers and institutions like Colby, can
choose to minimize the use of vinyl products to limit phthalate exposure.
It is difficult to find alternatives for PBDEs containing products because they are
so widely used and products aren’t labeled for fire retardants. It is possible to buy
furniture and fabric that has not been treated with PBDEs, buying furniture with organic
fabric is one alternative. Companies such as Dell and Apple computers have limited
PBDEs in their products and pledged to remove them from their products entirely.
To avoid PFCs one must avoid the products that are known to contain the
chemicals, such as Teflon ™, Gore-tex ™ and Stainmaster ™ carpet. As with PBDEs, it
isn’t always apparent if a product contains PFCs, so avoiding them can be difficult.
Knowing about Teflon™ and Gore-tex™ allows one to avoid PFCs in products.
Parabens, present mostly in cosmetics, can be avoided by choosing products
without parabens on the label. These products are becoming increasingly available as
public awareness increases.
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Potential Impacts on Colby Purchasing
Many factors enter into an institution’s purchasing decisions. If Colby were to
use my score as a way to analyze certain purchasing decisions on the basis of endocrine
health there are multiple ways it could be used. Using my scale the college could apply a
score to all products containing the chemicals I examined. By then developing a threshold
score, dangerous products could be identified. A product containing a chemical with a
threshold score (ex. 2) or higher could be examined and possibly eliminated. If indeed the
college decided to change their purchasing there are ways to limit the exposure to
hazardous endocrine disrupting chemicals.
•

Eliminate the campus wide distribution and sale of Nalgene™ water
bottles being sold in the bookstore.

•

Eliminate Poland Springs™ polycarbonate water coolers in the faculty
lounges.

•

Limit canned foods being served in the dining halls.

•

Limit furniture and electronics that are treated with polybrominated flame
retardants.

•

Eliminate the use of Teflon™ pans in the dining hall kitchen and
Stainmaster™ carpet could also be limited to reduce PFC exposure.

•

Eliminate the sales of cosmetics sold in the bookstore containing parabens
and phthalates.

In addition or instead of these changes the college could provide information to the
community on products they deemed hazardous. Informed personal choices resulting
from this action could additionally reduce the risk incurred by the community.
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Lessons Learned & Further Research
Creating a qualitative measure of health impacts is difficult. It is especially hard
when dealing with information that is not complete and difficult to actually quantify
much of the time. It was challenging to quantify the severity and extent of the health
impacts of these chemicals. Doing this project has given me a real respect for anyone
who tries to quantify risk in terms of human health.
It also has become evident to me that US toxic chemical regulations are generally
influenced by profit and are not necessarily protective of human health. Too often
industry does not have to generate safety data, is able to control and suppress the data,
and unduly influences government regulators. Precaution in environmental health is
something that we do not follow and unfortunately it has and inevitably will lead to
negative health outcomes.
More research needs to be conducted on endocrine disruption in general. Many of
the impacts of these chemicals are still unexplained and need to be clarified to completely
understand this process. The hormonal system is extremely complicated and it is easy to
imagine that we will never have it completely figured out.
All of these chemicals need to be researched more fully and their synergistic
impacts need to be explored. No one has just one of these chemicals in their body. It is
plausible that the synergistic impacts of these chemicals are far greater than their
individual impacts, which we have seen already, in the limited research that is available.
A more comprehensive way to analyze purchasing in general needs to be
established. An institution like Colby should not just focus on the health impacts or the
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economic effects of a purchasing decision. Having a method that includes all of the
factors that contribute to purchasing decisions would be invaluable. My scoring method
could be one part of this method.
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